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Characterisation of the Performance of an Absorbable 
Magnesium Stent by Experimental and Numerical Analysis 
Emmet Galvin 
Magnesium stents are a promising candidate in the emerging field of bioabsorbable 
stents and could obviate many of the limitations of current permanent stent 
platforms such as stent thrombosis and in-stent restenosis. In this study, viable 
magnesium stents were manufactured from WE43 magnesium alloy precursor tubes 
by a combination of laser cutting and chemical and plasma-based surface 
treatments. The mechanical and corrosion performance of the stent was elucidated 
via experiments. It was shown that the plastic strain that is induced in the stent 
struts during the deployment procedure has a critical influence in directing both the 
kinetics and the nature of subsequent corrosion processes in the alloy. The 
deployment and scaffolding characteristics of the stent were determined and 
contrasted with those of a commercial stainless steel stent. The magnesium stent 
was shown to support significantly higher levels of cyclic strain amplitude which 
plays a crucial role in reducing in-stent restenosis. This study provided new insights 
into the performance of a current magnesium stent design and material and 
demonstrated the influence of deployment induced corrosion on the long-term 
scaffolding ability of the stent. A finite element based phenomenological corrosion 
model was developed and calibrated based on the results of the corrosion 
experiments. A plastic strain parameter was introduced in the modelling framework 
to account for the effects of plastic strain on corrosion behaviour. The model was 
found to be capable of predicting the experimentally observed mass loss profile and 




1.1 Coronary Artery Disease and Stenting 
Coronary artery disease (CAD) is the largest cause of mortality in the western world 
and is responsible for over seven million deaths worldwide each year (Go et al., 
2013). The pathogenesis of CAD involves the formation of stenotic lesions (plaque) 
in the vessel walls leading to narrowing and hardening of the coronary arteries 
(Yutani et al., 1999). These lesions may decrease the lumen of the artery and the 
resulting restriction in blood supply (ischemia) can lead to myocardial infarction (MI). 
The treatment of CAD often involves the deployment of an endovascular 
stent at the stenosis in order to restore patency and prevent arterial recoil (Lally et 
al., 2006). However, stenting inflicts injury in the intimal and medial layer of the 
arterial wall which can induce a partial re-blocking of the artery known as restenosis 
(Scott, 2006). In-stent restenosis (ISR) results in the formation of intimal hyperplasia 
(IH) around the stent struts and represents a major limitation to the success of 
current stent procedures (Dangas et al., 2010). Bare-metal stents (BMS), which 
have typically been produced from corrosion-resistant materials such as stainless 
steel (316L) and cobalt chromium, are associated with complications such as 
elevated rates of ISR (~25%) and late stent thrombosis (LST) (<1%) (Kandzari et al., 
2013; Stone et al., 2004). 
In order to overcome these limitations, drug-eluting stents (DES) were 
developed. DES normally consist of a BMS platform with a drug-eluting coating that 
is intended to reduce IH (Gogas et al., 2014). Although DES have demonstrated 
lower rates of ISR (~3%) and target vessel revascularisation (TVR) (<10%) 
compared to BMS, stent thrombosis (ST) (<1%) and ISR remain a significant 
limitation (Dangas et al., 2013; Kandzari et al., 2013). Permanent BMS and DES 
have other major limitations such as restrictions to non-invasive imaging and future 
 3 
 
revascularisation procedures, long term disruption of native haemodynamics and 
vasomotor function, chronic inflammation and delayed endothelialisation (Sammel et 
al., 2013). DES patients require longer dual antiplatelet therapy (DAPT) courses (~3 
months) compared to BMS (~1 month) in order to minimise the risk of LST (Kim et 
al., 2009; Nishinari et al., 2013). Variations in ST, TVR and ISR outcomes have 
been observed among existing stent platforms but the optimum treatment strategy 
after stenting has yet to be determined (Dangas et al., 2010; Hoffmann et al., 2004). 
Hence, a new generation of bioabsorbable stents (BAS), which are gradually 
absorbed in the body, is attracting significant interest (Gogas et al., 2012; Haude et 
al., 2013; Nishio et al., 2012; Zhang et al., 2013). 
1.2 Bioabsorbable Stents 
There are a number of limitations associated with current BAS including relatively 
large strut thicknesses (~150 µm) and crossing profiles (~1.4 mm) (Gogas et al., 
2014), limited extensibility and a higher risk of strut fracture (Zhang et al., 2013). 
Several polymer BAS have been proposed (Gogas et al., 2012; Nishio et al., 2012) 
but they have yet to achieve the mechanical and surface properties of current BMS 
and DES (Jabara et al., 2009). Other concerns with polymers include toxicity and 
endarteritis (Palmerini et al., 2014). Compared to polymers, metals generally have 
superior mechanical properties for coronary stents. The potential of iron (Moravej et 
al., 2010a, 2010b; Peuster et al., 2006, 2001) and iron-manganese alloys 
(Hermawan et al., 2010a, 2008) has been studied, though the corrosion rate of iron 
appears too slow for coronary BAS (Peuster et al., 2006, 2001) and unwanted 
degradation products are retained in the arterial wall (Pierson et al., 2011). 
Recently, absorbable magnesium stents based on the WE43 alloy have 
shown promise in clinical trials (Erbel et al., 2007; Haude et al., 2013) and, could 
potentially obviate many of the limitations of traditional permanent stents. However, 
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limitations associated with current magnesium stents include relatively high rates of 
late lumen loss due to excessive IH formation and premature loss of scaffolding 
(Erbel et al., 2007; Haude et al., 2013). Accordingly, the widespread adoption of 
magnesium stents depends on further developments in the technology such as 
characterisation and optimisation of materials and stent designs, and improved 
understanding of the adsorption of magnesium in vascular tissues (Hermawan et al., 
2010; Kitabata et al., 2014; Zhang et al., 2013). 
To date, stents based on WE43 derivatives represent the only magnesium 
platform to go through clinical trials for coronary stents (Haude et al. 2013; Erbel et 
al. 2007). Despite this, only a limited amount of data regarding their mechanical and 
corrosion performance characteristics has been reported in animal (Di Mario et al., 
2004; Heublein et al., 2003; Waksman et al., 2006) and clinical (Bosiers et al., 2009; 
Erbel et al., 2007; Haude et al., 2013) trials. There is little information available in 
the literature with regard to the manufacture of magnesium stents (Demir et al., 
2012; Di Mario et al., 2004; Hassel et al., 2006; Wu et al., 2012). Fibre laser cutting 
and surface treatment of balloon-expandable AZ31 stents has been described 
(Demir et al., 2012; Wu et al., 2012); though no such study has been reported for 
WE43. Also, few studies have reported mechanical and corrosion performance data 
for WE43 precursor tubes (Pachla et al., 2012; Witte et al., 2008). 
When investigating the performance of metallic stents, it is desirable to 
conduct testing on the stent or on a sample of the precursor tube in the final form 
and finish, due to the influence of materials processing, size effects and surface 
treatments on mechanical and corrosion behaviour (Connolley et al., 2005; Jain et 
al., 2008). It is noted that few experimental studies have been reported to this end 
for magnesium stents, with the study of Wu et al. (Wu et al., 2012), on an AZ31 
stent, being the most pertinent to date. Many of the existing studies employ 
specimens that were prepared using materials processing and surface treatments 
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that differed from those of coronary stents (Bowen et al., 2013; Coy et al., 2010; 
Grogan et al., 2011; Kannan et al., 2008; Zhang et al., 2010). Furthermore, while a 
number of studies have examined the effects of mechanical loading on the corrosion 
of magnesium for near-constant (Grogan et al., 2011) and non-constant (Kannan et 
al., 2008; Winzer et al., 2008) loads, the influence of the loading that is induced 
during stent deployment on corrosion behaviour has not been extensively studied. 
A number of experimental studies have provided correlations between the 
magnitude of specimen stress and corrosion behaviour in magnesium alloys (Dietzel 
et al., 2010; Kannan et al., 2008; Winzer et al., 2008). However, plastic strain, and 
the accompanying deformation-induced changes in electrochemical behaviour have 
been shown to play a crucial role in the micro-galvanic corrosion processes that are 
observed in magnesium alloys (Snir et al., 2012; Wittke et al., 2014). Since the stent 
deployment procedure is known to induce large plastic strain in the struts (Murphy et 
al., 2003), it is hypothesised in this work that deployment-induced plastic strain plays 
a critical role in directing subsequent corrosion phenomena in magnesium stents 
and thus effects the scaffolding ability of these devices in the long-term. 
In addition to experimental corrosion testing, computational modelling of the 
corrosion process can provide important insights into the fundamental corrosion 
processes that lead to the degradation of magnesium stents. To date, only a small 
number of corrosion models have been developed for absorbable metallic stents, 
which were based on the finite element method (FEM) and used either a continuum 
damage mechanics (CDM) approach (Gastaldi et al., 2011; Grogan et al., 2011) or 
adaptive meshing (Grogan et al., 2014a). Typically, these models adopted a stress-
mediated approach to simulate the corrosion of magnesium stent geometries 
(Gastaldi et al., 2011; Grogan et al., 2014a). However, in this work, a plastic strain 
mediated phenomenological corrosion model of the corrosion behaviour of a 
magnesium alloy stent was developed to facilitate prediction of stent behaviour. 
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While previous studies involved large and computationally-expensive FE models 
that required high-performance computing capabilities (Gastaldi et al., 2011; Grogan 
et al., 2014a), the focus of this work was the development of a compact and 
computationally-efficient corrosion model that facilitated virtual testing of magnesium 
stents and other implants on a standard desktop computer. Such models provide 
short solution times which are especially useful in the preliminary stages of stent 
design where many cycles of design iteration are necessary (Xia et al., 2007). 
These models may find utility in the design of stents through device evaluation 
simulations and the optimisation of device geometries for prolonging structural 
integrity during the absorption process.  
1.3 Objectives of this Study 
The key aim of this study was the determination of the mechanical and corrosion 
performance of a WE43 alloy absorbable magnesium stent using a combination of 
experimental and numerical analysis. The mechanical performance of the stent was 
determined and compared to that of a commercial 316L stent in terms of a range of 
deployment, radial stiffness and cyclic strain amplitude metrics. The influence of 
deployment-induced plastic strain on the subsequent corrosion behaviour of the 
stent was elucidated. The corrosion rates, the dominant corrosion processes and 
the temporal corrosion-induced reduction in the mechanical integrity of the stent 
were revealed. Since the specimens were laser cut from precursor tubes and were 
prepared using surface treatments suited to processing magnesium stents, it was 
believed that such an approach provided a more accurate characterisation of the 
mechanical and corrosion behaviour of the stent than previous experimental studies 
on magnesium test specimens with processing histories, surface treatments and 
loading conditions that differed from those of coronary stents. 
A finite element (FE) based plastic strain mediated phenomenological 
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corrosion model, which was capable of modelling the corrosion of a three-
dimensional (3-D) stent structure, was developed in order to assess the 
performance of a corroding magnesium stent. The development of such a model, 
which was calibrated based on the results of corrosion experiments and solved on a 
standard desktop computer by means of a computationally-efficient algorithm, 
provided a fast,  convenient and inexpensive preclinical tool for testing the design of 
stents and other absorbable metallic implants. 
In order to achieve the aforementioned goals, the following tasks first needed 
to be completed (see Figure 1.1); 
• A suitable processing route had to be identified by which viable stents could 
be manufactured from precursor tubes of the WE43 alloy. 
• A range of experiments had to be developed so that the mechanical and 
corrosion performance of stents and other specimens could be determined.  
• A corrosion algorithm had to be developed in a suitable computer language 
for use in a commercial implicit FE software package. 
 
Figure 1.1 Flow chart of the key project steps  
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2. Literature Review 
2.1 Anatomy, Physiology and Biomechanics of Coronary 
Arteries 
The coronary circulation supplies oxygenated blood to the myocardium with the 
majority of flow occurring in diastole, when the heart is relaxed (Nichols et al., 2005). 
The left and right coronary arteries (LCA and RCA) originate at the base of the 
ascending aorta, at the aortic sinuses, where blood pressure is at its greatest in the 
systemic circuit (Martini, 2006), as shown in Figure 2.1(a). 
 
Figure 2.1 (a) Anterior view of the heart showing the coronary circulation (b) 
schematic of the layers of a coronary artery 
The RCA supplies blood mainly to the right atrium, portions of both ventricles 
and the conducting system of the heart including the sinoatrial and atrioventricular 
nodes. The LCA supplies the left ventricle, left atrium and interventricular septum. 
Towards the anterior surface of the heart it gives rise to a circumflex branch (LCX) 
and the left anterior descending (LAD) artery. The LCX curves around the coronary 
sulcus where it finally joins small branches of the RCA. The much larger LAD swings 
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around the pulmonary trunk and runs along the surface within the interventricular 
sulcus. The LAD supplies small tributaries continuous with those of the posterior 
descending artery through interconnections known as arterial anastomoses (Martini, 
2006). LAD arteries are of central importance in CAD pathophysiology as ISR after 
stenting is most common in the LAD (Holzapfel et al., 2005). 
The wall of a healthy coronary artery consists of three distinct concentric 
layers; intima, media, and adventitia, as shown in Figure 2.1(b). The intima is the 
innermost layer and consists of a single layer of endothelial cells (ECs) that grow on 
the internal elastic lamina (Humphrey, 2002). ECs align with the direction of blood 
flow and act as a selective barrier between blood constituents and the extravascular 
space while also preventing thrombosis (Hunt et al., 2002). The intima may also 
contain a thin layer of sub-endothelial connective tissue and axially-orientated 
smooth muscle cells (SMCs) (Humphrey, 2002). The media is the thickest and most 
significant layer in terms of mechanical compliance at physiological pressures and 
consists of SMCs in an extracellular network of elastin fibres and collagen fibrils as 
well as an aqueous ground substance (Holzapfel et al., 2000). The media is 
separated from the adventitia by the external elastic lamina. The adventitia is the 
outermost layer and consists largely of thick bundles of collagen fibrils with admixed 
elastin, fibroblasts, and nerves (and in some cases, a network of blood vessels 
called the vasa vasorum) (Holzapfel and Ogden, 2006). 
Coronary arteries display both active and passive mechanical behaviour 
(Fung, 1993). Active behaviour is determined by the contraction of SMCs that are 
arranged spirally around the vessel wall allowing them to function as control points 
for blood distribution. The highly non-linear passive mechanical properties of the 
multi-layered artery are dependent on many factors such as the relative amounts of 
elastin and collagen present, the age of the artery and the level of disease present 
(Holzapfel et al., 2005). 
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2.2 Coronary Artery Disease 
CAD (also known as coronary atherosclerosis or ischemic heart disease) is a 
condition involving the accumulation of plaque (an atheroma or lesion) in the walls of 
the coronary circulation leading to narrowing and hardening of the arteries 
(Holzapfel and Ogden, 2006), as shown in Figure 2.2. Low density lipoprotein (LDL) 
particles accumulate in the intima causing ECs to produce adhesion molecules that 
latch onto blood monocytes. The monocytes mature into active macrophages which 
ingest modified lipoprotein particles, ending up as fat-laden foam cells. SMCs 
proliferate and migrate to the intima promoting extracellular matrix accumulation in 
the growing atherosclerotic plaque (Zohdi et al., 2004). As the atheroma develops it 
increases in volume and may occlude the lumen of the artery thus restricting the 
blood supply to the myocardium leading to myocardial ischaemia. The mismatch in 
the mechanical properties of the vessel wall and the stiffer atheroma may also lead 
to rupture or detachment of the atheroma, creating a downstream clot (embolism) in 
the blood flow (Holzapfel et al., 2004). 
Risk factors for CAD include hyperlipidaemia, tobacco smoking, obesity, 
diabetes mellitus, hypertension, psychosocial and dietary factors, physical inactivity 
and a genetic disposition (Yusuf et al., 2004). The risk of CAD increases 
progressively with adult age and with the level of systolic blood pressures 
(Lewington et al., 2003). CAD may be treated by a number of interventional 
techniques including coronary artery bypass grafting (CABG), atherectomy, laser 
vaporisation techniques, percutaneous transluminal coronary angioplasty (PTCA) 
and stent deployment (Topol, 2008). CABG involves diverting the blocked blood flow 
through an alternative path using a vein or artery from elsewhere in the body or a 
prosthetic vessel in order to restore blood flow to the effected cardiac muscle. 
Specific advantages of CABG include the ability to revascularise chronic total 
occlusions (CTOs) and the ability to treat anatomic subsets that are not 
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approachable with stents (Topol, 2008). However, the CABG procedure is highly-
invasive and requires a considerable recovery period. It normally requires the heart 
to be stopped and therefore a cardiopulmonary bypass module is required. Although 
CABG has a low death rate it has associated complications and so is more 
commonly used for high-grade stenosis or occlusion (Drenth et al., 2002). 
 
Figure 2.2 Schematic representation of the process of atherosclerosis 
PTCA, also known as balloon angioplasty, involves making a small incision 
in the femoral artery and guiding a balloon catheter to the blockage site in the 
coronary arteries (Agema et al., 2004). The balloon is expanded thereby pushing the 
atheromatous plaque into the arterial wall, thus restoring vessel patency. Although 
PTCA is non-invasive, it is associated with high rates of restenosis (30-60%) due to 
elastic recoil of the arterial wall and/or the formation of IH (Mercado et al., 2001; 
Topol, 2008). Therefore, PTCA is often combined with stent implantation in order to 




Restenosis is the re-blocking of a stented arterial segment causing a reduction in 
luminal size and a restriction in blood flow. It primarily involves the formation of a 
neointimal layer that occurs as a result of an exaggerated healing response 
prompted by vascular injury (EC denudation, vessel wall stretching and sometimes 
plaque rupture) consequent to high pressure (10-20 bar) balloon expanded stent 
implantation (Kraitzer et al., 2008), as shown in Figure 2.3.  
 
Figure 2.3 Stent restenosis: the re-blockage of a stented artery owing primarily to 
the formation of neointimal hyperplasia 
The biological response to stenting may consists of four phases (Kraitzer et 
al., 2008; Welt and Rogers, 2002), as shown in Figure 2.4. 
 
Figure 2.4 Schematic representation of the restenosis process after stent 
implantation 
a) Platelet Aggregation: The arterial injury that occurs during the stenting 
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procedure (endothelial denudation and medial dissection) causes platelet 
aggregation and activation, thus initiating an inflammatory cascade and 
releasing adhesion molecules that trigger thrombus formation. The 
thrombosis that develops may be a major cause of vessel re-occlusion in the 
first month after stenting (Edelman and Rogers 1998). 
b) Inflammatory phase: Over days to weeks, a variety of white cells may gather 
at the injury site, secrete factors and influence the healing tissue. The 
inflammatory phase may persist for months. 
c) Proliferation phase: Between one and three months after stent implantation, 
SMC migration and proliferation and IH formation is the key mechanism of 
restenosis (Topol, 2008). SMCs migrate from the vessel media (and possibly 
adventitia) through the fracture of the internal elastic membrane to the intima 
where they may continue to proliferate and synthesise extra-cellular matrix 
(ECM); the major component of the restenotic lesion. 
d) Late remodelling phase: involves alterations in vessel wall geometry through 
redistribution of cells through processes such as selective cell 
proliferation/apoptosis, or matrix synthesis/degradation (Hunt et al., 2002) in 
order to adapt to the new strain environment imposed by the stent. Initial 
deformation consists of elastic recoil following balloon deflation. Later, 
geometric remodelling occurs as the artery shrinks, owing to collagen 
deposition and fibrosis. Although remodelling in a BMS and DES stented 
vessel is relatively small, the arterial wall may be squeezed through the stent 
strut gaps from without. The artery opposes the strain imposed by the stent 
struts through increased collagen deposition, marked destruction of elastin, 
and persistent inflammation (Edelman and Rogers 1998). As the amount of 
scar develops, blood flow is gradually reduced. 
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The classic binary definition of restenosis is an angiographically-measured 
obstruction of 50% diameter stenosis or more at the site of a previously treated 
coronary vessel (Briguori et al., 2000). When the lumen diameter is reduced to 50% 
or less, coronary flow reserves become impeded. Late loss is a continuous 
angiographic measure of lumen deterioration and is usually calculated by 
subtracting the minimum lumen diameter (MLD) at follow-up from the post-
procedural MLD (irrespective of the locations of MLD measurements). Late loss 
measurements in stented segments offer a surrogate marker of IH. Target vessel 
revascularisation (TVR) is defined as any repeat percutaneous coronary intervention 
(PCI) of the treated coronary segment or CABG of the target vessel. ISR can be 
characterised as focal (≤10mm long), diffuse (>10mm), proliferative (>10mm and 
extending outside the stent) or total occlusion (Dangas et al., 2010).  
The nature of restenosis appears to be related to the stent platform used 
(Sangiorgi et al., 2007). Restenosis with sirolimus-eluting stents is mostly focal 
(>90%) and located at the stent edges, whereas diffuse or total occlusion accounts 
for about 50% of restenosis cases after implantation of polymer-coated paclitaxel-
eluting stents (Topol, 2008). Studies have shown that many factors associated with 
the stent deployment procedure also contribute to restenosis outcomes, such as 
procedural complications (Castagna et al., 2001), stent-induced injury or stretch 
which is a function of maximum balloon pressure (Arakawa et al., 1998; Hoffmann et 
al., 2004; Schwartz et al., 1992) and the stent-to-artery ratio. Stent design variables 
also influence the biologic response to stent implantation (Hara et al., 2006), such 
as the number of struts (Briguori et al. 2002), strut thickness and profile (ideally <75 
µm) (Kastrati et al., 2001) (Palmaz, Benson et al. 1999), the release of toxic metals 
(e.g. Ni, Mo) (Köster et al. 2000; Saito et al. 2009) and haemodynamic factors 
(Duraiswamy et al., 2007). The largest alteration of shear stress in the blood occurs 
at the entry and exit segment of stents where IH is often focused (LaDisa 2006). 
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Stenting introduces significant and chronic alterations in the biomechanical 
environment of the cells within the local coronary arterial wall. The levels of stresses 
and strains are elevated compared to normal physiological conditions and these 
levels have been used as determinants in ISR development (Arakawa et al. 1998; 
Zahedmanesh et al. 2010). The proliferative vascular response in the restenosis 
process is exacerbated by the persistent stimuli of rigid metallic struts within the 
arterial wall (Topol, 2008). Vessel stiffness is increased by the presence of the 
expanded stent. Consequently, the cyclic strain environment in the artery is changed 
from a low-mean, high-amplitude strain environment to a high-mean, low-amplitude 
strain environment (Vernhet et al., 2000), as shown in Figure 2.5. In a stented artery 
the mean strain can increase by as much as 20-50% and the cyclic strain amplitude 
can fall as low as 1-2% (Vernhet et al., 2001, 2000). Cyclic strain amplitude is an 
important regulator of SMC growth capacity within a stented artery (Colombo et al. 
2012). Therefore, compliant stent designs that allow cyclic strain amplitude levels to 
remain close to the normal physiological range (5-8%) (Draney et al., 2002; Vernhet 
et al., 2000), and thus maintain the anti-proliferative effect of cyclic strain on SMCs, 
could offer an effective strategy to reduce the rates of ISR. 
 




2.3 Coronary Stents 
Coronary intravascular stents are cylindrical mesh structures which are expanded at 
the site of stenosis in order to scaffold the vessel walls and prevent elastic arterial 
recoil (Lally et al., 2006). Coronary stents are traditionally manufactured from 
materials such as stainless steel (316L), cobalt chromium, tantalum, titanium, nitinol 
or polymers (Sangiorgi et al., 2007). Stent deployment is normally achieved by 
expanding an angioplasty balloon (pressure >16 bar) onto which the stent has been 
crimped. Alternatively, deployment may be achieved by releasing a self-expanding 
stent or a coiled stent from a restraining sheath. Stents are used to mechanically 
support the vessel wall, to treat balloon or atherectomy device-induced coronary 
dissections, and to minimise post-procedure vessel recoil and late negative vascular 
remodelling (Savage et al., 1994; Topol, 2008). The stent diameter is normally 
selected to approximate a 1.1:1 ratio compared to the angiographically normal 
adjacent vessel, while stent length should cover the entire lesion length (Topol, 
2008). Advantages of stent procedures include relatively mild morbidity, fast 
reperfusion and rapid stabilisation of patients with MI. Limitations of stents include 
the inability to treat a CTO (Topol, 2008). 
2.3.1 Bare-Metal Stents 
The results of a number of clinical trials reported that bare-metal stents (BMS) 
reduced ISR rates from 35% with PTCA to 19% (Kandzari et al., 2002; Mercado et 
al., 2001). However, ISR and ST remain a major limitation of BMS implantation. In 
general, an event that occurs within 30 days of stenting is called an early stent 
thrombosis (EST). An event that occurs more than 30 days and 12 months after 
stent implantation is called a late stent thrombosis (LST), and a very late thrombosis 
(VLST), respectively. Studies have shown that LST is uncommon with BMS, and 
that events have a mean time of 2.4 to 3.6 months. Although the incidence of ST is 
low with BMS (<2% of cases) there is a high risk of MI or even death (Ong et al., 
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2005). In order to address the complications associated with using BMS, new types 
of drug-eluting stents (DES) were developed. 
2.3.2 Drug-Eluting Stents 
Typically, DES are composed of three principal components: the stent backbone 
(often a BMS platform), the pharmacologic agent (typically anti-proliferative drugs 
such as sirolimus, paclitaxel, taxus, zotarolimus or everolimus) which is intended to 
reduce IH and sometimes other effects, and a polymer designed to mediate 
abluminal drug release over a two-to-four week period (Bailey 2009) in order to 
reduce ISR (Garg & Serruys, 2010). Several clinical trials (CYPHER, RAVEL, 
SIRIUS, TAXUS, ENDEAVOUR, and SPIRIT) have been performed that 
demonstrate the ability of DES to significantly reduce ISR, LST and TVR rates 
(typically <3%, <1% and <10% respectively) compared to BMS (Dangas et al., 2013; 
Kandzari et al., 2013). Despite these improvements, limitations remain with regard 
to the safety and efficacy of DES in terms of late adverse clinical events, such as 
LST and ISR. The suggested mechanisms for ISR and ST with DES include in-stent 
neo-atherosclerosis, neointimal hyperplasia, persistent endarteritis, uncovered 
struts, stent malapposition (Colombo and Latib 2008), strut fracture (Alqahtani et al., 
2013; Aoki et al., 2007; Lim et al., 2008) and the persistent presence of the device 
(Sammel et al., 2013). Patients implanted with DES normally require DAPT for about 
3 months in order to minimise the risk of ST (Kim et al., 2009; Nishinari et al., 2013); 
though a number of side-effects are associated with DAPT (Albaladejo and 
Samama, 2010). Many experts suggest that continued development of permanent 
stents (BMS and DES) is not likely to eliminate these problems and therefore radical 
alternatives to conventional stents, such as bioabsorbable stents (BAS), must be 
developed (Di Mario and Ferrante, 2008). 
2.3.3 Bioabsorbable Stents 
After stent implantation, the local vascular healing response (re-endothelisation, 
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remodelling etc.) and the majority of cardiac events including ISR normally occurs 
within six-to-nine months (Edelman and Rogers, 1998), beyond which the utility of 
permanent stents is unclear (Colombo and Karvouni, 2000; Jabara et al., 2009; 
O’Riordan, 2006). Permanent stents interfere with normal vessel function and can 
induce adaptive changes and abnormal reactions in the local tissue (Hoffmann et 
al., 1996). Owing to the drawbacks of BMS and DES, intravascular stent technology 
has progressed toward the development of bioabsorbable stents (BAS) that 
temporarily scaffold the vessel during the initial period of high risk for recoil, and 
then degrade in the long term (Erne et al., 2006). The gradual loss of mechanical 
integrity due to the bioabsorption of the stent should reduce the stimuli for 
endothelial irritation, endarteritis, IH, and ISR (Williams, 2006) while facilitating the 
restoration of normal local vascular compliance and permitting positive late 
remodelling (Anis and Karsch, 2006). BAS may help avoid many of the long term 
problems of permanent stents, such as LST and ISR. BAS do not preclude repeat 
PCI or surgical revascularisation, may be used repeatedly in a single vessel, may be 
useful in paediatric patients where growth adaption and repeat PCI is often required 
and may provide new treatment options for diffuse disease and unstable or 
vulnerable atherosclerotic plaques (Gundogan et al., 2014). As the degradation of 
BAS and their polymer coatings is not expected before six months, it is unlikely that 
the minimum duration of DAPT for coated BAS will differ greatly from current 
metallic DES (Kim et al., 2009; Nishinari et al., 2013); though uncoated BAS could 
potentially minimise DAPT to one month or less in line with BMS guidelines (Levine 
et al., 2011). 
Stack et al. developed the first BAS, composed of poly-L-lactide (PLLA) and 
tested it in animal models (Stack et al., 1988). The Igaki-Tamai stent (Kyoto Medical 
Planning Co. Ltd, Kyoto, Japan) was the first coronary BAS implanted in humans in 
1998. The PLLA stent demonstrated safety and efficacy at 6 months (Tamai et al., 
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2000) and in a long-term (>10 years) study (Nishio et al., 2012). Currently, there are 
more than fourteen BAS available with the majority of these still under preclinical or 
clinical evaluation, as shown in Figure 2.6. A review of all current BAS platforms is 
beyond the scope of this work but may be found in (Gundogan et al., 2014; Zhang et 
al., 2013). Instead, the sections that follow focus on absorbable magnesium stents. 
Current BAS technology has a number of shortcomings that limit their 
application in current clinical practice such as relatively large strut thicknesses and 
crossing profiles (Gogas et al., 2014), limited extensibility and higher risk of strut 
fracture (Zhang et al., 2013). BAS pose significant development challenges. The 
ideal period that a coronary stent needs to remain in place is unknown, though some 
clinicians suggest six-to-nine months may be sufficient (Colombo and Karvouni, 
2000). Also, stent manufacturers are proposing different BAS solutions such as 
polymeric, bare-metal, hybrid, and drug-eluting BAS platforms. An effective BAS 
should possess a number of characteristics such as similar or better acute and long 
term performance compared to current generation metallic DES, adequate radial 
strength, steerable biodegradation kinetics, minimal or zero inflammatory or 
thrombotic response with normal endothelial function and non-toxic degradation 
products that leave no residual substances in arterial tissues (Bailey, 2009; Topol, 
2008; Weiß et al., 2009). While PTCA, BMS, and DES are regarded by many as the 
first, second, and third revolution of interventional cardiology, BAS are being 
heralded by many as the fourth revolution (Onuma and Serruys, 2011). The global 
coronary stent market, which had a value of €5.5 billion in 2012, is expected to grow 
to €7.75 billion by 2016, with BAS projected to account for about €1.3 billion of this 




Figure 2.6 Details of current bioabsorbable stents (BAS) platforms (adapted from 
(Zhang et al., 2013)) 
Magnesium Stents 
The efficacy of an absorbable magnesium stent was first investigated by Heublein et 
al. who implanted a prototype stent made from the AE21 alloy in porcine coronaries 
(Heublein et al., 2003). The first absorbable magnesium stent (AMS-1, Biotronik AG) 
implanted in human coronaries was manufactured from the WE43 alloy, as shown in 
Figure 2.7(a). However, the corrosion rate and loss of scaffolding was too rapid and 
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resulted in relatively high rates of late vessel recoil. The absence of an anti-
proliferative drug on the AMS-1 also led to high rates of IH and ISR (Erbel et al., 
2007). In order to address these limitations, the DREAMS-1 stent (AMS-3, Biotronik 
AG) had a revised alloy (non-commercial WE43 derivative) and stent design which 
incorporated a paclitaxel-eluting polylactide-co-glycolide (PLGA) coating, as shown 
in Figure 2.7(b). Lower recoil and IH were reported and the corrosion profile was 
extended with restoration of normal vasomotor function reported at six months. The 
stent was shown to be safe and demonstrated modest efficacy with regard to late 
recoil and TVR rates (Haude et al., 2013). A number of design iterations were made 
to the DREAMS-2 stent including the use of tantalum markers on a revised stent 
design and a sirolimus-eluting PLA coating, as shown in Figure 2.7(c).  
 
Figure 2.7 Magnesium coronary stent platforms manufactured by Biotronik AG: (a) 
AMS-1, (b) DREAMS-1 and (c) DREAMS-2 
Compared to DREAMS-1, DREAMS-2 showed increased flexibility, larger 
deployment diameter capability, improved endothelialisation and reduced 
inflammation in preclinical trials (Guy, 2013). A PLGA coating that used a mixture of 
85% lactide and 15% glycolide provided the lowest intimal area at 28 days and 180 
days, and the highest endothelialisation score at 28 days in a porcine model 
(Wittchow et al., 2013). The alloy used in DREAMS-2 (WE43 derivative) degraded 
(0.036-0.072 mg cm-2 day-1) into a magnesium-rich compound containing a large 
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amount of oxygen, most likely in the form of magnesium carbonate (MgCO3) and 
Mg(OH)2 after 28 days in a porcine artery model, as shown in Figure 2.8. These 
compounds were converted into a soft and gel-like amorphous calcium phosphate 
product after 90-to-180 days implantation. The accumulation of calcium products in 
the arterial wall may be of concern as it could potentially act as a precursor to 
atherosclerotic plaque which is calcium-rich (Holzapfel et al., 2004); though this 
requires further investigation. The performance of DREAMS-2 is being assessed in 
the BIOSOLVE-II trial which commenced in late 2013.  
 
Figure 2.8 SEM images and EDX mapping of DREAMS-2 degradation products after 
28, 90 and 180 days implantation in porcine coronary arteries (Wittchow et al., 2013) 
Investigations are on-going to assess the utility of various other magnesium 
alloy systems for stent applications such as Mg-Y-Zn (Hänzi et al., 2010), Mg-Zn-Zr 
(Hong et al., 2013), Mg-Zn-Mn (Fang et al., 2013) Mg-Zn-Y-Nd (Wu et al., 2012), 
Mg-Nd (Seitz et al., 2012) and Mg-Li (Zhou et al., 2013), amongst others. The 
ZMED stent (Zorion Medical, IN, USA) is a wire-form, balloon-expandable fully-
absorbable drug-eluting BAS composed of a (RE-free) proprietary magnesium alloy. 
Preclinical studies showed that the device was completely absorbed with minimal 
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inflammatory tissue response within ninety days. Further preclinical evaluations are 
needed before a first-in-human study which will begin in early 2015 (Zorion Medical, 
2014). Other companies with absorbable magnesium stent programs include 
Medtronic Inc. MN, USA (magnesium alloy stent with sirolimus coating), Boston 
Scientific Corporations MA, USA (magnesium alloy) and QualiMed Innovative 
Medizinprodukte GmbH, Winsen, Germany (magnesium alloy and polymer hybrid).  
The aforementioned trials have shown that magnesium stents are safe and 
feasible within small study groups and for simple lesion types. Despite this, only a 
limited amount of data regarding their mechanical and corrosion performance 
characteristics has been reported in animal (Di Mario et al., 2004; Heublein et al., 
2003; Waksman et al., 2006)  and clinical (Bosiers et al., 2009; Erbel et al., 2007; 
Haude et al., 2013) trials. Therefore, studies that can reveal the mechanical and 
corrosion performance of magnesium stents are needed. Further, the elucidation of 
the biomechanical environment that is supported by magnesium stents may prove 
crucial in helping to solve the problem of ISR owing to the influence of cyclic strain 
amplitude and stent radial stiffness on the development of restenosis (Colombo et 
al., 2012; Vernhet et al., 2001). 
WE43 was selected for this study as it was used in multiple generations of 
the Biotronik AMS platform (AMS-1 to AMS-4) and currently represents the only 
magnesium stent platform to successfully go through clinical trials for coronary 
(Haude et al. 2013; Waksman et al. 2009; Erbel et al. 2007) and peripheral (Bosiers 
et al. 2005; Bosiers et al. 2009) applications. However, limitations associated with 
current magnesium stents include low mechanical properties compared to 
commercial BMS and DES, relatively high rates of late lumen loss due to excessive 
IH formation and premature loss of scaffolding (Erbel et al., 2007; Haude et al., 
2013), and biocompatibility concerns associated with alloying elements that may 
remain in vascular tissues after stent degradation (Feyerabend et al., 2010). 
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These limitations can be addressed in future through the development of 
high-purity magnesium alloys (particularly with minimal impurities such as Fe, Cu, Ni 
and Si) alloyed with high-purity hardeners (non-misch metal) and alloying elements 
(such as Zn, Nd, Zr, Y) that are biocompatible and safely eliminated from arterial 
tissues following device degradation (Li and Zheng, 2013). Ultra-fine or nano-
crystalline magnesium alloys offer significantly improved mechanical and corrosion 
performance and may be obtained by a number of severe plastic deformation (SPD)  
techniques that are the subject of on-going research and development (Zheng et al., 
2014). Further improvements in corrosion performance and stent biocompatibility 
(improved endothelialisation, reduced inflammation and IH, ISR and ST rates) will 
be achievable through surface modification techniques, such as surface treatments 
and coating and drug elution strategies specific to magnesium alloys (Hornberger et 
al., 2012). 
2.4 Magnesium and Magnesium Alloys 
Magnesium is essential to human health and is involved in numerous metabolic 
reactions and biological mechanisms (Hruby and McKeown, 2013). Magnesium 
deficiency is common in industrialised nations and can increase our susceptibility to 
many illnesses, including CAD and stroke (Hartwig, 2001). Oral magnesium 
supplementation can improve endothelial health (Fuentes et al., 2006), offer a 
modest reduction in CAD risk (Mathers and Beckstrand, 2009) and can aid skeletal 
growth and development. The risk of hypermagnesemia is low as the kidneys very 
efficiently excrete excess magnesium (Birrer and Shallash, 2002). Absorbable 
magnesium implants were first explored in the early twentieth century but were later 
abandoned due to the inherent rapid corrosion and evolution of hydrogen (H2) gas 
subcutaneously (Witte, 2010). Recent progress in magnesium metallurgy, further 
understanding of corrosion processes, and the development of corrosion protection 
techniques has seen a burgeoning interest in magnesium biomaterials (Song, 2011).  
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Magnesium alloys possess many physical and chemical properties that 
make them highly-suited for use in coronary stents such as low thrombogenicity and 
high biocompatibility (Erbel et al., 2007), suitable mechanical properties (Zheng et 
al., 2014) favourable corrosion kinetics (Kirkland et al., 2010) and zero 
magnetisation (MRI and CT compatible) (Staiger et al., 2006). The metabolic 
conversion of magnesium to its chloride, oxide, sulphate, and phosphate salts is well 
tolerated in vivo and the resulting by-products are not retained in the arterial wall 
(Bowen et al., 2014). Intravenous administration of magnesium has been shown to 
be safe and acts as a systemic and coronary vasodilator (Fuentes et al., 2006). In 
vitro testing involving human cells has shown that magnesium can control SMC 
proliferation and stimulate ECs (Sternberg et al., 2011). Extensive preclinical testing 
has shown that bare-metal and drug-eluting magnesium-based absorbable stents 
are both safe and feasible (Erbel et al., 2007; Haude et al., 2013). 
Although the mechanical properties of pure magnesium are too low for load-
bearing implants such as stents, the strength, ductility and corrosion resistance of 
magnesium can be significantly improved by developing high-purity alloys (Zainal 
Abidin et al., 2013) and by using alloying elements which aid precipitation and solid-
solution hardening (Yang et al., 2008). Micro-alloying with RE elements such as Y, 
Zr, Nd and Ce produces ductile alloys with high fatigue strength and fine 
microstructural features that can restrict grain growth during solidification and pin 
grain boundaries during later thermo-mechanical processing (Song, 2011). 
Therefore, RE alloys such as WE43 are of particular utility in stent manufacturing 
where the material is repeatedly subjected to thermo-mechanical processing steps 
such as tube drawing and stress-relief by annealing (T-5 and T-6 heat treatments) 
(Hänzi et al., 2010)), and in-service where the stent is subject to cyclic loading under 




2.4.1 The WE43 Alloy 
WE43 typically contains (by weight %) approximately 93% magnesium, 3.7-4.3% 
yttrium (Y), >0.4% zirconium (Zr), with the remainder (2.4-4.4%) consisting of RE 
elements, principally Neodymium (Nd) (2.0-2.5%) and heavy RE elements such as 
Ytterbium (Yb), Erbium (Er), Dysprosium (Dy) and Gadolinium (Gd) (Magnesium 
Elektron, 2007). Zr is a potent grain-refining agent in magnesium alloys and 
contributes to strengthening due to the formation of fine grains by grain boundary 
strengthening (Avedesian and Baker, 1999). Y and Nd are used mainly to increase 
strength and service temperature, and to improve creep and corrosion resistance 
(Zhang et al., 2009). Y is commonly added to magnesium alloys in the form of Y-rich 
misch metal which contains impurities (such as Fe, Ni and Si) that may be 
detrimental to corrosion performance (Song and Atrens, 2003). Moreover, Y-rich 
misch metal contains approximately 20% by weight of other RE elements (such as 
Nd, La, Dy, Ho, Er, Tm, Yb and Lu) (Zhang et al., 2009). The effects of these RE 
elements in vivo is not completely understood though in vitro studies involving 
human SMCs suggest that some RE elements may have cytotoxic effects and 
negative influences on inflammatory reactions (Drynda et al., 2009; Feyerabend et 
al., 2010). 
One of the notable features of Mg-Y alloys is that they exhibit both solution 
and age-strengthening effects; these being strongly linked to the solubility of Y in α-
Mg matrix and the volume of intermetallic phases (Zhao et al., 2011). The Mg-Y and 
Mg-Zr phase diagrams are shown in Figure 2.9(a) and (b), respectively. From these 
phase diagrams it can be seen that a small change in composition can result in 
different phases and hence different material properties occurring. Therefore, control 
of the composition is important. The process of grain refinement using Zr may be 
described with reference to the phase diagram shown in Figure 2.9(b). For alloys 
such as WE43 which are saturated with Zr in the liquid phase, cooling allows some 
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precipitation of α-Zr particles as the freezing temperature is approached. At the 
peritectic temperature (~654°C), suspended Zr particles can form nuclei for the 
peritectic reaction with Zr-saturated Mg liquid to produce solid α-Mg with high Zr 
content. Owing to the close similarity in Mg and Zr lattice parameters, on final 
solidification a relatively homogenous distribution of fine hexagonal grains forms 
which reflects the growth mode of the two components. As maximum solubility of Zr 
is necessary for obtaining the highest grain refinement, some elements which form 
stable high melting point compounds with Zr should ideally be removed and not be 
present in Mg-Zr alloys such as Al, Si, Fe, Ni, Mn Sn, Co and Sb (Friedrich and 
Mordike, 2006). 
 
Figure 2.9 Phase diagrams (a) Mg-Y (b) Mg-Zr (Li et al., 2013; Zhao et al., 2011) 
The microstructure of wrought and heat-treated WE43 normally consists of 
recrystallised grains with a large volume fraction of precipitates within the α-
magnesium matrix. Typically, the precipitates present include (1) Mg12(RE,Y) 
polyhedral precipitates located within the matrix at grain boundaries, (2) spherical 
Zr-rich and cubic Y-rich precipitates, both containing Fe and Si impurities and (3) 
needle-like β-phase precipitates, as shown in Figure 2.10 (Coy et al., 2010). The 
relative Volta potential differences between micro-constituent phases and the α-
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magnesium matrix indicate the corresponding role of the micro-constituent phases in 
potential galvanic interactions. In the case of WE43, Zr-rich precipitates exhibit 
greater volta potential differences (+180 mV) when compared to Y-rich precipitates 
in the presence of Fe (0.2 at.%) (+90 mV), Mg12(Nd,Y) (+25 mV) and β-phase 
precipitates (+15 mV) (Coy et al., 2010). 
 
Figure 2.10 Backscattered scanning electron micrograph of wrought WE43 alloy 
(Coy et al., 2010) 
2.4.2 Mechanical Properties of Magnesium Alloys 
A useful review of the mechanical properties of many current absorbable 
magnesium alloys was presented by Li and Zheng (Li and Zheng, 2013). Studies 
have reported moderate to strong asymmetry in the mechanical properties (ratio of 
yield stress in tension and compression) of magnesium alloy tubes with consistently 
lower properties observed in compression when compared to tension (Gunde et al., 
2011; Vedani et al., 2012). This has been attributed to the crystallographic texture of 
samples and to the occurrence of preferred {10–12} <10–11> twinning in 
compression. Heat treatment provides an effective method to reduce asymmetry, 
which is advantageous with respect to the fatigue behaviour of stents where the 
lower of the tensile or compressive yield stress value determines the fatigue 
strength (Frey et al., 2005). A number of studies have reported mechanical 
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properties for extruded WE43 derived from heat-treated bulk test specimens (Gu 
and Zheng, 2010; Magnesium Elektron, 2007; Witte et al., 2008). However, bulk 
specimens have very different materials processing histories to stents and the 
presence of size effects means that the mechanical behaviour may not capture the 
true behaviour of the device (Connolley et al., 2005; Murphy et al., 2003; Savage et 
al., 2004; Wiersma and Taylor, 2004). The processing of magnesium alloy stent 
precursor tubes has been described in a number of studies (Fang et al., 2013; Ge et 
al., 2013, 2011; Hassel et al., 2006). To date, few studies have reported mechanical 
property data for stent precursor tubes of the WE43 alloy (Witte et al., 2008) or other 
magnesium alloys (Hassel et al., 2006; Kutniy et al., 2009); though the surface 
treatments used in these studies differed to those used for coronary stents. 
Generally, these studies did not report on the geometry of the specimens used and 
either employed no surface finishing or simple mechanical polishing of specimens. 
The mechanical properties for WE43 reported in these studies is summarised in 
Table 2.1. Material property data that is derived from WE43 precursor tubes and 
from specimens with similar size scale and surface treatments as coronary stents 
are necessary. As well as revealing the true mechanical behaviour of finished WE43 
stent strut materials, such experimental data would serve as input in future 
computational models of magnesium stent performance. 
 
Table 2.1 Available data for the mechanical properties of WE43 specimens 
2.4.3 Corrosion of Magnesium Alloys 
Magnesium is one of the most anodic metals having a standard electrode potential 
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of -2.37 V. Therefore, with magnesium there is often a high chance of galvanic 
corrosion relative to other metal elements (Song, 2011). The corrosion processes 
and reaction kinetics of magnesium alloys depend on parameters including 
composition of the alloy, metallurgical treatment, surface treatment, composition of 
the interacting electrolytes, chemistry and biology of the environment, and the 
transport and metabolic phenomena associated with the reactants and the corrosion 
products (Bowen et al., 2012). The body electrolyte contains many anions (mainly 
chloride, phosphate, and bicarbonate ions), cations (mainly Na+, K+, Ca2+ and Mg2+), 
organic substances and dissolved gases such as oxygen (Ratner et al., 1996). The 
high corrosion rates of magnesium alloys in vivo and in simulated body fluid (SBF) 
are generally attributed to the influence of aggressive ions such as chlorides, 
phosphates, sulphates and carbonates (Xin et al., 2008). Magnesium surfaces do 
not naturally passivate in aqueous chloride-containing solutions at physiological pH 
levels (Song, 2011) and so accelerated corrosion can be expected (Zhao et al., 
2008). The corrosion attack in aqueous environments often involves galvanic 
coupling between anodic and cathodic areas that result in preferential dissolution of 
the (anodic) magnesium matrix (alpha (α) phase) and cathodic reduction of water 
(Zeng et al., 2006). The chemical process associated with the attack can be 
summarised as follows: 
Anodic reaction: −+ +→ eMgMg 22   
Cathodic reaction: −− +→+ OHHeOH gas 222 )(22   
Combined reaction: )(2)(22 )(2 gassolid HOHMgOHMg +→+  
Generally, the dissolution rate of the α-phase exceeds the formation rate for 
the magnesium hydroxide (Mg(OH)2) surface layer and so corrosion is not easily 






MgCl2, thus accelerating magnesium dissolution. The evolved H2 gas causes further 
detachment of the surface layer and increases the surface alkalinity (Kainer, 2003). 
Several studies have shown that magnesium alloys with fine-grained 
microstructures exhibit significantly higher corrosion resistance in chloride-
containing environments as compared to coarse-grained microstructures (Alvarez-
Lopez et al., 2010; Amira et al., 2008; Argade et al., 2012; Kannan, 2010; Song et 
al., 1999). This has been attributed to the higher fraction of continuous β-phase that 
is more finely distributed around finer α-grains and acts as a barrier to galvanic 
corrosion (Song et al., 1999). Fine-grained microstructures show lower porosity, 
higher polarisation resistance and the most positive pitting potentials and re-
passivation potentials (Argade et al., 2012). The corrosion products (mainly 
magnesium oxide (MgO)) formed on the surface of fine-grained alloys are more 
protective against the action of chloride ions (Alvarez-Lopez et al., 2010). A one 
order of magnitude decrease in corrosion rate was observed between a coarse-
grained (70 µm) and fine-grained (~0.7 µm) Mg-Y-RE alloy (Argade et al., 2012). 
Crystallographic orientation in magnesium alloys has a strong influence on surface 
processes such as corrosion, dissolution and oxidation (Song and Xu, 2012). The 
influence of crystallographic orientation was shown to be about 10% of the total 
corrosion depth for pure magnesium (Liu et al., 2008). Also, the highest corrosion 
resistance was observed for grains near (0001) orientation which are commonly 
found on the processed surfaces of precursor tubes. 
A comprehensive discussion of all corrosion processes affecting magnesium 
alloys is outside the scope of this work but can be found in (Atrens et al., 2011; 
Song and Atrens, 1999). The main corrosion processes expected to influence the 
behaviour of magnesium alloy stents in vivo (Gastaldi et al., 2011) are discussed 
here, including micro-galvanic and localised (pitting and filiform) corrosion, inter-




The non-uniformity in the composition, microstructure, and crystalline orientation of 
magnesium alloys can induce various chemical and electrochemical activities within 
the material resulting in micro-galvanic corrosion which leads to dissolution and 
thinning of the metal (Coy et al., 2010). Some areas, grains, phases, particles and 
impurities may act as anodes while others act as cathodes, as shown in Figure 
2.11(a). Magnesium is susceptible to corrosion owing to galvanic activity among its 
primary constituents namely, primary α, eutectic α and β-phases, as shown in Figure 
2.11(b). The magnesium α-matrix is an anode and is preferentially dissolved due to 
its lower content of alloying elements (Kalb et al., 2012) leading to undermining and 
fallout of the secondary phase particles, as shown in Figure 2.11(c). 
 
Figure 2.11 (a) Galvanic corrosion (internal) in magnesium alloys. (b) Galvanic 
activity among the primary α, eutectic α and β-phases and (c) the resulting 
morphology. (e) a continuous β-phase inhibits corrosion and (f) the resulting 
morphology 
The β-phase serves as a galvanic cathode and accelerates the corrosion of 
the α-phase if the volume fraction of β-phase is small. However for a high volume 
fraction, a continuous β-phase can act as a barrier to inhibit corrosion (Atrens et al., 
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2011), as shown in Figure 2.11(d and e). Galvanic corrosion processes at grains 
and grain boundaries can also be accelerated by deformation (plastic strain) in 
metal parts (Krawiec et al., 2012). In the case of a deformed stent strut, the tensile 
side of the strut may be anodic with respect to the compression side, leading to 
increased galvanic corrosion (Ratner et al., 1996). 
Localised Corrosion 
Pitting Corrosion: Pitting corrosion is a localised electrochemical reaction that 
leads to the formation of small pits on the affected surface. It can be initiated on 
stent surfaces by several processes such as damage of the passive film, localised 
plastic yielding during crimping and expansion, the production of stents with 
improperly polished surfaces, particle inclusions, inhomogeneous crystallinity or 
crystal defects causing dislocations to emerge on the surface and nonhomogeneous 
environments containing aggressive chemicals, such as chloride, causing localised 
dissolution of the passive film (Song, 2011). Pitting corrosion tends to initiate at 
irregular pits that spread laterally over the whole surface but may not form deep pits 
owing to the self-limiting nature of localised corrosion in magnesium (Song and 
Atrens, 2007). 
Filiform Corrosion: Filiform corrosion is instigated by an active corrosion cell that 
migrates across the metal surface; the head is the anode and the tail is the cathode 
(Song and Atrens, 1999). Filiform corrosion does not occur on uncoated pure 
magnesium though it has been reported for anodized and coated magnesium 
materials (Lamaka et al., 2008) as well as for alloys with relatively resistant surface 
oxides (Lunder et al., 1994) such as the AZ series. 
Inter-Granular Corrosion (IGC) 
The grain boundaries are preferred sites at which precipitation and segregation of 
the β-phase occurs in magnesium alloys (Zeng et al., 2006). Magnesium alloys 
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rarely exhibit inter-crystalline attack because the grain boundary phases are 
invariably cathodic to the grain interior; instead, corrosion is normally concentrated 
in the area adjoining the grain boundary and may proceed until the grain is undercut 
and falls out (Song, 1999). IGC with rapid material dissolution and grain detachment 
has been reported for WE43 owing to selective attack of eutectic shaped Nd-based 
compounds at grain boundaries which act as anodic sites due to their low 
electrochemical potential with respect to grain areas (Valente, 2001). Additions of Zr 
may also lead to IGC in WE43 (Song, 2011).  
Stress Corrosion Cracking 
Stress corrosion cracking (SCC) results from a combination of static stress (either 
applied or residual) and a corrosive environment (as opposed to corrosion-fatigue 
where loading is dynamic) (Ratner et al., 1996). With magnesium alloys, corrosion 
may be initiated at a microscopic crack tip that does not re-passivate (Winzer et al., 
2007). This leads to brittleness at the tip of the crack, because the H2 gas evolved 
during the corrosion process is absorbed (Winzer et al., 2005b). Incremental crack 
growth may then occur resulting in implant failure. SCC is more marked in wrought, 
rather than cast magnesium alloys and is mainly transgranular in nature. SCC does 
not occur in pure magnesium and only occurs in Zr-containing alloys such as WE43 
as stresses approach the yield stress (Song and Atrens, 1999). 
Fatigue Corrosion 
Stents are subject to cyclic (fatigue) mechanical loading due to the pulsatile nature 
of blood flow. The resulting strain, abrasion or wear may continuously rupture the 
surface passivation layer thereby reducing the corrosion resistance of the exposed 
material, thus increasing the number of metallic ions released (Ratner et al., 1996). 
Further, if a crack is present, anodic dissolution may occur at the tip of a crack. 
Corrosion fatigue is highly-significant as there is no limiting stress (endurance limit) 
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below which corrosion-induced cracking will not occur. In their study on WE43, Gu 
et al. (Gu et al., 2010) showed that the fatigue strength of samples in air was 
significantly reduced in static SBF and further reduced in dynamic SBF. Under the 
influence of cyclic loading the corrosion rate of specimens was shown to increase 
and a toughness fracture mode was identified where a crack initiated at a corrosion 
pit and propagated through the material. 
2.4.4 Influence of Stent Manufacture on Magnesium Alloys 
To date, a detailed study of the influence of laser cutting on the performance of 
WE43 stents has not been reported. The laser cutting of magnesium alloys requires 
the use of an inert shield gas (e.g. Ar or Nitrogen) rather than the use of O2 which 
results in the formation of a refractory layer of MgO in the kerf which reduces cutting 
efficiency (Demir et al., 2013). Laser processing has been shown to increase the 
mechanical properties and reduce the micro-hardness of WE43 by influencing 
factors such as solid–solution strengthening, dislocations,  second phase particles 
and geometrical constraints posed by grain boundaries that obstruct dislocation 
motion (Santhanakrishnan et al., 2013). A number of studies report significant 
increases in the corrosion resistance of magnesium alloys owing to the influence of 
the rapid heating and cooling induced in the HAZ during laser processing (Abbas et 
al., 2005; Guo et al., 2005; Liu et al., 2005). This has been attributed to 
morphological changes in the material microstructure such as significant grain 
refinement and the redistribution of intermetallic phases (Abbas et al., 2005). Higher 
concentrations of alloying elements on the machined surface, which aid the 
formation of more protective oxide films, have been reported for laser-processed 
magnesium alloys (Liu et al., 2005). Laser cutting stents from magnesium precursor 
tubes exposes higher index crystal planes of lower corrosion resistance (Liu et al., 
2008). Hence, in the absence of sufficient surface treatment and HAZ removal, 
reduced corrosion resistance might be expected on these surfaces. 
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There are numerous surface treatment techniques available for the surface 
modification of magnesium alloy implants (Hornberger et al., 2012; Ma et al., 2014; 
Zheng et al., 2014). Chemical etching is often used with magnesium alloys in order 
to replace the native oxide layer with a more passive and corrosion resistant oxide 
layer (conversion coating) of lower porosity and lower surface roughness (Nwaogu 
et al., 2009). The chemical conversion layers,  which are formed in a complex 
interaction of metal dissolution and precipitation in the aqueous solution, mainly 
consist of magnesium phosphate, MgO, Mg(OH)2 and mixtures of other metal oxides 
and hydroxides, which arise from the dissolved ions in the bath (Gray-Munro et al., 
2009). As the layers are grown in situ, adhesion to the substrate is good and the 
surfaces obtained facilitate the adherence of any subsequently deposited coating 
(Hornberger et al., 2012). In the case of AZ31 stents, chemical etching in a nitric 
acid solution has been used to remove the heat-affected zone (HAZ), dross and 
spatter that were formed on surfaces during laser cutting (Demir et al., 2012). Gray-
Munro et al. described chemical etching in phosphoric acid solution in order to form 
a non-toxic coating on AZ31 specimens (Gray-Munro et al., 2009). The increased 
corrosion resistance observed was attributed to improved surface uniformity and 
crystallinity of the protective Mg(OH)2 and magnesium phosphate layer that was 
produced by etching. Zhou et al. described the formation of a magnesium phosphate 
coating on an AZ91D specimen in three main phases: (1) corrosion of the 
magnesium matrix, (2) mass transposition in the liquid phase and the metal-solution 
interface, and (3) formation and growth of crystal nucleus (Zhou et al., 2008). Layer 
growth was attributed mainly to formation of Mg(OH)2 at the substrate-layer interface 
by anodic reaction and dissolution mainly of the magnesium matrix material. 
In medical device manufacturing, gas plasma processes offer useful surface 
modification (Yang et al., 2010) and sterilisation (Halfmann et al., 2007) techniques 
for devices with complex shapes, such as coronary stents. Plasma etching can be 
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used to remove manufacturing residues, foreign materials and bio-burden and offers 
a clean, safe and environmentally-friendly alternative to traditional wet chemical 
processes. Materials are removed from the surface by chemical reactions (to form 
volatile products) and physical sputtering using inert gases such as argon or neon. 
Due to the low energy of the gas plasma, layers of atoms are gradually removed 
from the surface without significantly modifying the microstructure of the substrate 
material (Yang et al., 2010). It has been shown that O2 plasma processing of 
biomaterials leads to increased surface wettability (Yi et al., 2004) and enhanced 
adhesion properties for any subsequently deposited coating (Nakamura et al., 1996) 
which are of particular utility in the manufacture of coronary stents. 
2.5 Computational Modelling of Magnesium Stents 
The deployment of magnesium alloy stents by simple pressure and displacement 
loads have been simulated in a number of FE studies (Sabir et al., 2012; Wang et 
al., 2009). Grogan et al. (Grogan et al., 2012) compared the mechanical 
performance of magnesium, iron, 316L and Co-Cr stents, based on multiple stent 
platforms and predicted a higher fracture risk for magnesium stents owing to the 
lower plasticity of the material. Computational models based on crystal plasticity 
theory have been used to predict the influence of size effects in stent struts and 
highlight the improvement in deformation performance of magnesium stents for 
decreasing material grain size (Grogan et al., 2013). Similar model have been used 
to investigate the failure risk and load-bearing capacity of magnesium stent struts 
undergoing plastic deformations typical of stent expansion (Grogan et al., 2014b). 
Wu et al. (Wu et al., 2010) applied an iterative morphing procedure in order 
to reduce the predicted concentrations of stress and strain in a 2-D RUC strut model 
during a stent deployment simulation. This procedure was combined with the 
corrosion model of Gastaldi et al. (Gastaldi et al., 2011) in a shape optimisation 
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study of a 3-D stent structure in order to identify a stent design that displayed lower 
mass loss and hence a prolonged scaffolding profile. The model was validated 
based on preliminary corrosion experiments that involved the optimised AZ31 stent 
design (Wu et al., 2012). A similar shape optimisation model was reported by Li et 
al. (Li et al., 2014) where model validation was based on experimental corrosion 
testing of unfurled stent geometries cut from AZ31 sheets. Although not discussed 
here, a number of corrosion models have also been developed and applied in 
computational studies of magnesium stents. This is discussed in section 2.5.1. 
With the exception of the crystal plasticity models described above, many of 
the aforementioned computational studies employ FE modelling based on 
continuum plasticity theory where the material model parameters were derived from 
mechanical testing of specimens that did not have the same processing history as 
can be expected for magnesium stents (Gastaldi et al., 2011; Grogan et al., 2012, 
2011; Wu et al., 2011, 2010). Therefore, improvements in the predictive capabilities 
of future FE models, based on continuum plasticity theory, may be obtained through 
the use of mechanical properties derived from specimens of precursor tube that 
have surface treatments similar to magnesium stents. 
2.5.1 Corrosion Modelling 
Several numerical models for external galvanic corrosion, based on the boundary 
element method (BEM), in which different galvanic couples are studied have been 
proposed for fixed (Jia et al., 2006) and moving mesh (Deshpande, 2010; Thamida, 
2012) techniques. A mathematical model for micro-galvanic corrosion that 
accounted for the negative difference effect (NDE) that is observed in magnesium 
alloys was proposed by Liu and Schlesinger (Liu and Schlesinger, 2009). A 
numerical model for micro-galvanic corrosion within a binary phase metal alloy was 
developed by Deshpande (Deshpande, 2011) using the Arbitrary Langrangian 
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Eulerian (ALE) method. The model used the non-linear polarization behaviour of the 
alloy phases and tracked the moving boundary of the degrading phase. A 
mathematical model based on potential theory and calibrated based on in vivo 
corrosion data was used to show that the thickness of the electrolyte influenced the 
galvanic corrosion of magnesium (Montoya et al., 2014). A macroscale corrosion 
damage internal state variable (ISV) model that captured the effects of general 
corrosion, pit nucleation, pit growth, pit coalescence, and intergranular corrosion 
was developed by (Walton et al., 2014) and applied to the AZ31 magnesium alloy. 
Models of other corrosion processes have been developed and applied to 
magnesium alloys such as stress corrosion cracking (SCC) (Dietzel et al., 2010) 
fatigue cracking (Xue et al., 2007) and crevice corrosion (Sun et al., 2014). 
Many of the aforementioned modelling approaches focus on specific 
corrosion processes that are not easily applicable to coronary stents due to the 
difficulty of establishing the model parameters by experimental calibration 
procedures, as well as the high computational costs associated with 3-D 
geometries. Therefore, a number of alternative models been developed specifically 
for modelling the corrosion of absorbable metallic stents. As numerical modelling of 
the various complex phenomena affecting the corrosion performance of metallic 
stents in vivo represents a significant challenge and as such this represents a 
relatively new field of research, only a small number of phenomenological (Gastaldi 
et al., 2011) and physical (Grogan et al., 2014a) corrosion models have been 
developed and applied to magnesium stents.  
A phenomenological corrosion model was developed by Gastaldi et al. 
(Gastaldi et al., 2011) using the CDM approach and implemented within a FE 
framework in order to account for the effects of stress corrosion and uniform micro-
galvanic corrosion processes on the behaviour of a 3-D magnesium alloy stent 
geometry. The model was calibrated from experimental corrosion studies performed 
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on mechanically polished cylindrical specimens of extruded magnesium alloys 
(AZ31, AZ61, AZ80, ZK60 and ZM21). The same corrosion model was later 
calibrated from experimental studies performed on specimens that were cut from 
magnesium alloy sheets and extruded bars and used to perform optimisation studies 
for magnesium stents in which outputs such as stress, strain, acute and corrosion-
induced stent recoil and mass loss were examined (Wu et al., 2011, 2010). In a 
combined experimental and numerical study, Wu et al. (Wu et al., 2012) produced 
an AZ31 stent and compared experimentally observed elastic recoil and mass loss 
with those predicted by the corrosion model. 
Grogan et al (Grogan et al., 2011) added an element-specific pitting 
corrosion parameter to the damage law developed previously by Gastaldi et al. 
(Gastaldi et al., 2011) in  order to incorporate the effects of heterogeneous or pitting 
corrosion in the modelling framework. The model was calibrated based on corrosion 
experiments involving mechanically polished AZ31 foil specimens and was used to 
predict the corrosion-induced recoil and mass loss of an AZ31 stent that was 
deployed in an idealised coronary artery model.  
A physical corrosion model, based on the FEM and adaptive meshing, was 
developed by Grogan et al. (Grogan et al., 2014a) to model the diffusion-controlled 
corrosion of a 3-D (pure magnesium) stent strut section. The study was predicated 
on a transport-controlled process, based on the assumption that metallic ion 
transport, particularly diffusion, was slower than the electrochemical reaction rate for 
the stent surrounded by layers of corrosion product and tissue in the body. The 
model predicted that the mass loss rate was proportional to the saturation 
concentration of magnesium ions in solution. The diffusivity of the surrounding 
environment was also shown to influence the corrosion rate. 
The aforementioned corrosion models of magnesium stent performance 
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(Gastaldi et al., 2011; Grogan et al., 2011) involve stress-mediated corrosion 
processes. However, since the stent deployment procedure is known to induce large 
plastic strain (20-30%) (Murphy et al., 2003) corrosion models that explore the 
interaction of plastic strain and plastic damage with corrosion damage are required. 
Indeed, this has been recognised as one of the current challenges in degradable 
material modelling (Gastaldi et al., 2011). Further, these corrosion models were 
calibrated from corrosion experiments that used magnesium specimens that had 
materials processing, surface treatments, and loading regimes that were dissimilar 
to those of coronary stents which are all known to bear a significant influence on the 
mechanical and corrosion behaviour of magnesium materials (Gastaldi et al., 2011; 
Grogan et al., 2011). This is also true of many of the experimental studies of the 
corrosion performance of absorbable magnesium materials and devices that are 
currently available in the literature (Bowen et al., 2013; Coy et al., 2010; Grogan et 
al., 2011; Kannan et al., 2008; Zhang et al., 2010). Therefore, mechanical and 
corrosion experiments that use specimens with appropriate processing and loading 
histories relevant to magnesium stents are required in order to reveal the true 
behaviour of these devices. Such an approach should provide improvements in the 
quality of the experimental data obtained. Such data would also prove useful in the 
calibration and validation of numerical corrosion models of magnesium stent 
behaviour. 
2.6 Summary 
The optimum treatment strategy to resolve the problem of ISR following stenting 
with BMS and DES platforms has yet to be determined. Emerging strategies include 
bioabsorbable stents (BAS) which provide temporary arterial scaffolding and are 
absorbed in the body after six-to-thirty six months (Zhang et al., 2013). BAS 
materials under investigation include polymers and absorbable metals, such as iron 
and magnesium. Absorbable magnesium stents have shown promise in extensive 
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clinical trials (Erbel et al., 2007; Haude et al., 2013). However, these trials typically 
involved small patient cohorts and simple lesions and therefore performance 
comparison with commercially-available stents is difficult. Only limited performance 
data has been reported for magnesium stents in general and in particular for WE43 
alloy stents which, to date, represent the only magnesium stent platform to go 
through coronary trials. It is known that the stent deployment characteristics, radial 
stiffness, and cyclic strain amplitude in a stented artery segment influence ISR 
outcomes (Colombo et al., 2009; Sangiorgi et al., 2007; Topol, 2008). As yet, these 
performance characteristics have not been reported for WE43 stents. 
Ideally, in vitro performance assessment should be conducted on the 
finished stent or on samples of the precursor tube in the final form and finish owing 
to the influence of processing, surface treatment and size effects on device 
behaviour (Connolley et al., 2005; Murphy et al., 2003; Savage et al., 2004; 
Wiersma and Taylor, 2004). It is noted that while a number of experimental studies 
have reported on the mechanical and corrosion performance of magnesium test 
specimens (Bowen et al., 2013; Coy et al., 2010; Grogan et al., 2011; Kannan et al., 
2008; Zhang et al., 2010) and simplified unfurled stent geometries that were cut 
from sheets (Li et al., 2014; Wu et al., 2010), few studies have employed finished 
magnesium stents as specimens (Wu et al., 2012) and no such studies have been 
reported for WE43 stents. Many of the experimental studies of absorbable 
magnesium materials in the literature employed specimens that had materials 
processing, surface treatments and loading regimes that differed to those of 
coronary stents (Bowen et al., 2013; Coy et al., 2010; Grogan et al., 2011; Kannan 
et al., 2008; Zhang et al., 2010); Therefore, the mechanical and corrosion behaviour 
of these specimens may not be representative of finished magnesium stents. Only a 
limited about of information regarding the mechanical and corrosion behaviour of 
WE43 stent precursor tubes is available (Witte et al., 2008). Fibre laser cutting and 
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surface treatment of balloon-expandable stents has been reported for the AZ31 alloy 
(Demir et al., 2012; Wu et al., 2012); though no such study has been reported for 
WE43.  
While a number of studies have investigated the effects of mechanical 
loading on the corrosion of magnesium specimens for near-constant loads (Grogan 
et al., 2011) and non-constant loads (Kannan et al., 2008; Winzer et al., 2008), the 
influence of the stent deployment procedure on the corrosion performance of 
magnesium stents has not been extensively investigated. A number of experimental 
studies have attempted to correlate the magnitude of stress in the magnesium 
specimen to corrosion behaviour and have subsequently developed stress-mediated 
corrosion models of magnesium stent performance (Gastaldi et al., 2011; Grogan et 
al., 2011). Plastic strain, and the accompanying deformation-induced changes in 
electrochemical measurements in magnesium alloys have been shown to have a 
significant effect on galvanic corrosion processes, which are prominent in 
magnesium alloys (Snir et al., 2012; Wittke et al., 2014). 
Since the stent deployment procedure is known to induce large plastic strain 
(20-30%) in stent struts (Murphy et al., 2003), we hypothesise that the plastic strain 
that is induced in magnesium stents during the deployment procedure plays a 
critical role in directing subsequent corrosion phenomena in the stent and therefore, 
has an influence on the scaffolding ability of the stent in the long-term. Therefore, in 
this work, plastic strain levels consistent with the deployment procedure were 
induced the stents and specimens produced and the resulting effects on the 
mechanical and corrosion performance of the specimens were explored in 
experiments. The data were also used in the development and calibration of a 
plastic strain mediated phenomenological corrosion model capable of simulating the 
corrosion behaviour of magnesium alloy stents.  
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3. Materials and Methods 
3.1  Summary 
Absorbable magnesium stents were laser cut from precursor tubes of the WE43 
alloy. Surface treatments were performed using a combination of chemical etching 
and plasma etching processes. The manufacture and surface treatment of the 
WE43 stents used in this study is discussed in detail in (Galvin et al., 2013). 
The mechanical performance of the magnesium stent was compared to that 
of a commercially-available 316L stent in three separate tests that determined stent 
deployment, radial strength and cyclic strain amplitude metrics. 
The corrosion behaviour of stent and dogbone specimens was determined 
via immersion corrosion experiments performed in SBF under pseudo-physiological 
conditions. The influence of the deployment procedure on the corrosion behaviour of 
the stent was investigated in terms of temporal mass loss and corrosion-induced 
loss of mechanical integrity.  
A corrosion algorithm was written in ANSYS parametric design language 
(APDL) and was developed for use with the ANSYS Implicit FE code. The corrosion 
model, which was calibrated from the experimental data, was used to simulate the 
corrosion performance of the magnesium stent. The results predicted by the model 
were compared to those observed experimentally.  
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3.2 Stent Manufacture 
3.2.1 Laser Cutting 
Coronary stents were manufactured from stent precursor tubes of the WE43 
magnesium alloy. An initial compositional analysis of the tube was performed to 
confirm that the content of magnesium and the three main alloying elements (Y, Zr 
and Nd) was consistent with that specified by the manufacturer of WE43 
(Magnesium Elektron, 2007), as shown in Appendix A.1. The tubes had an outer 
diameter of 2.1 mm and a wall thickness of 0.15 mm. The stent design was 
approximated from published images of the Biotronik AMS-1 platform (Di Mario et 
al., 2004). The unfurled stent geometry was first modelled in a computer-aided 
design software package (SolidWorks Corp., MA. U.S.A), as shown in Figure 3.1(a). 
 
Figure 3.1 (a) Two-dimensional CAD model of the unfurled stent geometry (b) SEM 
image of a tube in which the stent pattern was machined 
The computer-aided design data were then used to produce a computer 
numerical control (CNC) program that defined all cutting paths necessary to sculpt 
the stent by pulsed fibre laser machining (Starcut Tube, Rofin Baasel, UK Ltd.). The 
laser beam had a wavelength of 1070 ± 5 nm and diameter of 13 µm. Nitrogen was 
employed as an inert shield gas. A SEM image of a tube, in which the stent pattern 
was machined, is shown in Figure 3.1(b). 
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Figure 3.2(a) shows the stent after laser cutting with the sections of waste 
material removed. A significant amount of dross and spatter adherence was 
observed on the inner surface of the struts, as shown in Figure 3.2(b). This dross 
was subsequently removed by a combination of chemical and plasma etching 
processes. The finished stent had a length of 11.94 mm and an outer diameter of 
2.09 mm. The thickness of struts in the radial and longitudinal direction was 140 µm 
and 120 µm, respectively. The average stent mass was 4.5 mg. The total surface 
area of the stent was 78 mm2, as estimated from the computer model. 
 
Figure 3.2 (a) Machined stent remaining after the inner sections had fallen out (b) 
dross that formed on the inner surfaces as a result of laser cutting process 
3.2.2 Chemical Etching 
A chemical etching process was employed to remove the bulk dross, spatter and 
heat-affected zone (HAZ) that were formed during laser cutting. This process also 
rounded-off strut edges and improved the surface finish and stent deployment 
characteristics. The stents were chemically etched in 85.2% phosphoric acid 
(P6560, Sigma Aldrich) at 55°C for 20 seconds and then neutralised immediately by 
immersion in sodium hydroxide solution (100g/L, S8045, Sigma Aldrich) for 30 
seconds at 20°C. The stents were sonicated in ultrapure H2O for 2 minutes, followed 
by alcohol for a further 2 minutes. Specimens were dried for 2 hours in a cleanroom 
environment (class 100) using a glass drying oven (B-585, BUCHI Labortechnik AG) 
at an air temperature of 25°C (Morshed et al., 2011). 
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3.2.3 Plasma Etching 
In order to remove residues remaining from the chemical etching process the stents 
were placed in the chamber of a reactive ion etching (RIE) instrument (PlasmaLab 
80 Plus, Oxford Instruments). A schematic diagram of the experimental setup used 
for the plasma etching process is shown in Figure 3.3.  
 
Figure 3.3 Schematic diagram of the experimental setup used for the plasma 
etching process 
As RIE acts mainly as a “line-of-sight” process, etching was performed in 
three stages where the specimens were manually rotated in increments of 120° on a 
quartz plate in order to minimise shadowing effects. A capacitively-coupled plasma 
was generated by a 13.56 MHz radio-frequency (RF) power source. The RF-
powered electrode was made from stainless steel and had an outer diameter of 240 
mm. The grounded electrode was made from stainless steel and acted as a 
showerhead to supply the process gases. The distance between the powered and 
grounded electrodes was 46 mm. Plasma etching was performed in two separate 
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process steps using two different process gases. In the first step, the surfaces of the 
stents were plasma etched in a mixture of 90% argon (Ar) and 10% oxygen (O2) gas 
for a total of 10 minutes. The comparatively heavy Ar ions removed material by a 
micro-sandblast effect upon striking the substrate (Chu et al., 2002). In the second 
step, the stents were cleaned and sterilised in 100% O2 gas for a further 10 minutes. 
O2 plasma reacts with molecules deposited on the substrate breaking them down 
and turning them into volatile compounds (Chu et al., 2002). In both cases the 
process conditions were kept constant where the chamber pressure was 100 mTorr, 
the power was 250 W and the flow of gas was 100 sccm. A bias voltage of ~495 V 
was recorded. 
3.2.4 Surface Characterisation 
Specimens of the WE43 tube having a length of 10 mm were laser cut, then 
degreased by sonication in alcohol and finally placed in a glass drying oven for 2 
hours at 25°C. The tube specimens were subjected to the same chemical and 
plasma etching processes that were used to produce the stents. Specimens were 
prepared in three different conditions, namely as-received, chemically etched and 
plasma etched. Scanning electron microscopy (SEM), Atomic Force microscopy 
(AFM) and Energy Dispersive X-ray Spectrometry (EDX) analyses were performed 
on the tube specimens in order to characterise the morphology, roughness and 
chemical composition of surfaces for the three different conditions. 
EDX Analysis 
Prior to EDX analysis all specimens were sputter-coated with a thin film of carbon in 
order to render them conductive. EDX analysis was performed using an INCA 
Energy 350 XT microanalysis system (Oxford Instruments) in conjunction with a 
SEM (Leo 440 Stereo Scan, Leica Cambridge Ltd). The vacuum in the chamber was 
2.0 x 10-6 mbar. The beam current and spot size of the electron gun was set to 1.0 
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nA and 520 nm, respectively. The working distance between the specimen and 
electron gun was maintained between 8.5 and 9 mm and the collection time for the 
EDX detector was 120 seconds. Quantitative EDX analysis was performed using the 
INCA Microanalysis Suite (v4.09) software package. Background correction was 
performed using the background modelling method where the detector background 
spectrum was subtracted from the observed spectral distribution by mathematical 
filtering using a top hat function. The intensity of spectral peaks corresponding to 
specimen elements were measured and compared to standards measured under 
known operating conditions by the software. Intensity ratios (k values) were 
calculated and converted into chemical concentration (weight %) for the elements 
detected within the specimen. 
Surface Roughness Analysis 
The surface texture of treated and untreated specimens was scanned using high 
resolution contact mode AFM (Nano-R™ O-020, Pacific Nanotechnology). A 
cantilever AFM tip (SICON-10P, Applied NanoStructures Inc.) was drawn along the 
outer surface of each specimen in the longitudinal direction. Three randomly 
selected regions, measuring 80 µm x 80 µm, were scanned on each specimen. The 
scan rate and number of lines in each scan were kept constant at 0.5 Hz and 256, 
respectively. The surface roughness parameter (Sa) was calculated without a 
filtering process using the SPM CockpitTM (V3.3.383) software package according to 
the formula listed in ASME B46.1. A one-way analysis of variance (ANOVA) was 
used to test for differences among the surface roughness values (Sa) of the three 
specimen groups (as-received, chemically etched and plasma etched). 
3.3 Mechanical Testing 
Mechanical testing was carried out in order to determine deployment and cyclic 
strain amplitude metrics for the stent. A commercially-available generic modular 
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316L stent design (outer diameter (OD) = 3.5 mm, length = 9 mm, strut thickness = 
0.09 mm) was also tested for comparison, as shown in Figure 3.4(b). Prior to 
deployment, each WE43 stent was mounted (uncrimped) on a 3.5 x 18 mm 
angioplasty balloon. The 316L stents were already crimped to the balloon (3.5 x 18 
mm) on their delivery system when supplied. Stent performance was assessed in 
three different bench tests as described below. The tests were captured by 
videoextensometer and calibrated image sequences were used to calculate stent 
performance metrics. In each one of the three tests, three WE43 stents (n=3) and 
three 316L stents (n=3) were used. 
Non-uniform deployment may be encountered with manually crimped stents 
(Morton et al., 2004) and was likely to occur with the WE43 stent due to its highly-
compliant nature. Therefore, in this work, all WE3 stents were expanded without 
manual crimping to the angioplasty balloon in order to ensure a uniform deployed 
stent configuration. The crimping process induces significant compressive loading 
and deformation in stents and is known to change the subsequent stress-strain 
behaviour of the strut material during the deployment procedure, resulting from the 
tension-compression reversal behaviour (Bauschinger Effect) (Oberhofer et al., 
2006). Thus, compared to uncrimped stents, crimped magnesium stents would likely 
exhibit slightly reduced mechanical properties and altered fatigue and corrosion 
behaviour owing to the influence of material deformation and residual compressive 
stresses (Zeng et al., 2008). The use of crimping machines may be necessary with 
magnesium stents in order to reduce asymmetries in the deployed configuration 
which have been associated with increased vascular injury and higher rates of IH 
and ISR (Schulz et al., 2000). In a preliminary FE study carried out in this work, a 
crossing profile of 1.3 mm was predicted for the WE43 stent which was comparable 




Test 1: Free Expansion 
Stents were freely expanded to a maximum balloon pressure (15 atm) and then 
permitted to undergo elastic recoil. Expansion behaviour was quantified through the 
determination of a pressure-diameter curve where the balloon pressure and the 
corresponding stent OD were tracked during the free expansion procedure. The 
stent diameter was calculated from the average of eight separate OD 
measurements made along the length of the stent, as shown in Figure 3.4(a). In 
order to account for differences in the strut thickness of the two stent types, stent 
performance metrics were calculated using stent ID data. This was derived from the 
OD measurements by subtracting the strut thickness in the radial direction.  
 
Figure 3.4 Free expansion of stents (a) Location of 8 stent OD measurements taken 
using a videoextensometer during bench testing (b) 316L stent 
Test 2: Expansion in Mock Coronary Arteries 
Stents were expanded inside mock coronary arteries (MCAs) that were prepared 
using a technique described in an earlier work (Colombo et al., 2010). The MCAs 
had an inner diameter of 3 mm and a wall thickness of 0.4 mm. A pre-stretch ratio of 
1.1 was applied to each MCA using a custom fixture fitted with a linear translation 
stage and micrometer thereby mimicking the arterial tethering observed in vivo. 
Elastic longitudinal recoil (ELR), foreshortening (FS) and dogboning (DB) metrics 
were calculated using previously described formulae (Migliavacca et al., 2002). 




separate locations along the stent length, as shown in Figure 3.4. It was not possible 
to accurately measure the stent ID or OD by visualisation owing to the opacity of the 
MCA material. Therefore, ERR was calculated from measurements of MCA OD. 
 
Figure 3.5 Stent expansion in mock coronary arteries (a) WE43 stent (b) 316L stent 
Test 3: Cyclic Strain Amplitude 
The cyclic strain amplitude supported by expanded stents in MCAs was assessed, 
as shown in Figure 3.6. A static pressure head was applied to each stented MCA by 
elevating a tank of non-corrosive solution to a predetermined height. The tank was 
connected to the stented MCA using silicone tubing and luer lock fittings. Each 
stented MCA was subjected to three pre-conditioning pressure cycles (0 to 120 mm 
Hg). The OD of the stented MCA was recorded at eight separate locations while 
under the influence of three different static pressure loads, namely: 0, 80 and 120 
mm Hg. Cyclic strain amplitude was calculated as the % change in the average OD 
of the stented MCA between a pressure of 80 mm Hg and 120 mm Hg. 
 
Figure 3.6 Stented mock coronary artery under the influence of static pressure head 
during the experiment performed to measure cyclic strain amplitude 
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3.4 Corrosion Experiments 
The corrosion behaviour of dogbone and stent specimens was characterised 
through two independent immersion corrosion experiments performed in SBF, as 
detailed in Table 3.1. A total of eighty four dogbone specimens and twenty one 
stents were prepared for corrosion testing by laser cutting and finished using the 
surface treatments described in section 3.2. 
 
Table 3.1 Details of the experiments performed (PCM: phase contrast microscopy) 
The main purpose of Experiment A was the determination of the influence of 
plastic strain on the corrosion behaviour of the alloy. The corrosion rates, the 
dominant corrosion processes and the temporal corrosion-induced reduction in the 
mechanical integrity of the specimen were determined. Specimen mass loss was 
obtained by gravimetric measurements performed using a semi-microbalance 
having a resolution of 0.01 mg (Sartorius RC210P). The results of a preliminary 
corrosion experiment indicated a maximum specimen mass loss of almost 100% 
after 10 days of immersion. Assuming the requirement of having 500 increments (1 
increment = 0.01 mg) of measurement available within the expected experimental 
mass loss range, a specimen gauge region with a mass of approximately 5 mg was 
deemed suitable. As WE43 had a relative density of 1.84, the corresponding volume 
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in the specimen gauge region was 2.73 mm3. The wall thickness of the specimen 
was the same as that for the finished stent. In accordance with ASTM standard E8, 
which requires a minimum gauge length (L) to width (W) ratio of four for pin-loaded 
tensile specimens, an L/W ratio greater than five was selected in this case. Thus, 
the finished dogbone specimen, which is shown in Figure 3.7(a), had a gauge region 
with a length of 10.05 mm, (unfurled) width of 1.85 mm, wall thickness of 0.14 mm 
and a total surface area of 40 mm2. It is noted that the L/W ratio used in this work is 
similar or greater to those of previous studies involving tensile testing of sub-size 
metal specimens (Jain et al., 2008; Raulea and Goijaerts, 2001). Thickness 
measurements of the gauge region, performed using a SEM, verified that a uniform 
specimen wall thickness was obtained from the surface treatments. The average 
roughness (Sa) of outer specimen surfaces was 0.17 µm, as measured using AFM. 
In order to investigate the influence of plastic strain on corrosion behaviour, 
three groups of dogbone specimens were prepared, each subjected to a different 
magnitude of plastic strain, namely: 0%, 2.7% and 8.4%. Specimens having 0% 
plastic strain required no deformation. The other specimens were mounted in 
custom grips in a tensile testing machine (Z005, Zwick Roell) and extended for a 
time of 10 seconds by either 4% or 10% of their original length using a crosshead 
speed of 0.5 mm/min, as indicated by the stress-strain curves shown in Figure 
3.7(b). At peak extension the direction of crosshead travel was reversed in order to 
permit elastic recoil of the specimen and the test was terminated when the load cell 
recorded zero force. In this way, the specimens were subjected to a loading cycle 
analogous to that induced in stent struts (loading and elastic recoil) during the 
deployment process. After recoil, the plastic strain (PS) for the specimen groups 
(mean ± SD) was 2.66 ± 0.03% and 8.38 ± 0.02%; for simplicity these specimen 
groups were named 2.7% PS and 8.4% PS, respectively. The tab regions on each 




Figure 3.7 (a) The dogbone specimen geometry (b) Representative stress-strain 
response of dogbone specimens during the application of plastic strain 
The main purpose of Experiment B was to determine the corrosion rate for 
expanded WE43 stents and to determine the influence of corrosion on the radial 
stiffness of the stent. Each stent was mounted (uncrimped) on a 3.5 x 18 mm 
angioplasty balloon, freely expanded to a maximum balloon pressure (15 atm) 
consistent with clinical deployment of magnesium stents (Erbel et al., 2007) and 
then permitted to undergo elastic recoil. 
Prior to corrosion testing, stent and dogbone specimens were stored in a 
desiccator for 24 hours to ensure consistent oxidisation of all surfaces and then 
sterilised by exposure to ultraviolet irradiation for 2 hours. Specimens were mounted 
on a stage (Multiclip, Struers) so that all test region surfaces were exposed to the 
solution. Each specimen was placed in a separate container with 25 ml Hank’s 
balanced salt solution (H8264, Sigma Aldrich) and the screw cap of the container 
was left slightly open in order to allow gaseous exchange with the environment. The 
ratio of solution volume (ml) to exposed specimen surface area (cm2) was 63:1 and 
32:1 for dogbone and stent specimens, respectively; well above the minimum ratio 
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recommended for magnesium alloys (Yang and Zhang, 2009). Since corrosion 
phenomena in magnesium alloys are sensitive to variations in environmental 
conditions such as temperature (Kirkland et al., 2010), solution pH (Ng et al., 2010) 
and biological contaminants, the corrosion studies were performed under sterile 
conditions in an incubator (Nuaire NU-5500E) that provided temperature uniformity 
(37 ± 0.2°C) and a humidified gas environment (5% CO2 and 95% air) for increased 
pH buffering capacity.  
The pH of the SBF was recorded at regular time intervals (pH 213, Hanna 
Instruments) and maintained within a physiologically-relevant range of values (6.3–
7.8) as described in previous studies involving similar alloys and solutions (Bowen et 
al., 2013). Specimens were removed at various intervals of time, cleaned in a 
solution of 10% chromic acid (27081 Sigma-Aldrich) at 55°C in order to remove 
corrosion products and weighed using a semi-microbalance. For each interval of 
time four dogbone specimens (n=4) and three stents (n=3) were used. Corrosion 
surfaces were imaged under the SEM. The thickness of corroded struts was 
measured at 30 separate locations under the SEM, from which the mean strut width 
was calculated. EDX analysis was used to determine the elemental composition of 
the corrosion products and surfaces. Specimens were imaged in solution using a 
phase contrast microscope (PCM) (Olympus CK30) in order to observe the evolution 
of H2 gas bubbles. 
Mechanical strength testing was performed to determine the influence of 
corrosion on the mechanical integrity of the specimens. For dogbone specimens, 
uniaxial tensile testing was carried out to failure in one loading cycle using a 
materials testing machine (Z005, Zwick Roell) with a 5 kN load cell. A pre-load of 0.5 
N and a crosshead speed of 0.5 mm/min were used. Tests were terminated when 
the load dropped below 70% of the maximum load value. Specimen elongation was 
determined from crosshead travel, rather than from local deformation at the test 
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region of the specimen. Specimen stresses were calculated based on the original 
specimen cross-section and so the changes in cross-section due to necking and 
corrosion were not accounted for; this approach having been used previously in 
similar studies (Bowen et al., 2012). Engineering stress-strain curves were produced 
for each specimen. The elastic modulus (E), 0.2% offset yield strength (σy) and 
ultimate tensile strength (UTS) were calculated in accordance with ASTM E111-04 
using the TestXpert software package (V11.02). The value of strain at the UTS and 
at failure was termed the ultimate strain (εu) and failure strain (εf), respectively. The 
radial stiffness of stents, defined as the change in resistive force for an applied 10% 
reduction in stent diameter, was evaluated by compressing freely expanded stents 
between the platens of a materials testing machine (Zwick Z005) using a 500 N load 
cell, a preload of 0.02 N and a cross-head speed of 0.2 mm/min. Again, the 316L 
stent was tested for comparison. Data were normalised for the 316L stent in order to 
account for the difference in original length between the 316L and WE43 stent and, 
curves were presented as stent reaction force versus stent compression. 
3.5 Corrosion Modelling 
A FE based plastic strain mediated phenomenological corrosion model, which was 
capable of modelling the uniform micro-galvanic corrosion of a 3-D metallic stent 
structure, was developed in order to assess the performance of a corroding WE43 
alloy stent. The model was used to predict the effects of diffusion-controlled 
corrosion in elastic-plastic metals and, was calibrated through corrosion experiments 
that established the plastic strain-mediated input corrosion rates for the material of 
interest. The corrosion model was written in ANSYS parametric design language 
(APDL), as shown in Appendix A.3 and, was developed for use with the commercial 
ANSYS Implicit FE code. APDL is a scripting language specific to ANSYS that 
facilitates automation of common tasks, parameterisation of models and, allows the 
use of other sophisticated features, such as optimisation techniques (Ansys, 2010). 
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The corrosion model developed represents a modification of the CDM model 
proposed by Gastaldi et al. (Gastaldi et al., 2011) which allows the effects of 
corrosion-induced micro-scale geometric discontinuities on overall specimen 
mechanical integrity to be accounted for, without explicitly modelling their 
progression. However, in this study, a discrete rather than continuum modelling 
approach was adopted. A flowchart outlining the operation of the corrosion model is 
shown in Figure 3.8. After the solution to an initial analysis was obtained (stent 
deployment and recoil), the results data, which included the magnitude of the first 
principal plastic strain, εp1, in each element, was written to arrays in preparation for 
corrosion simulation. Element connectivity was determined and the elements on the 
corrosion surface were identified. The material behaviour of each element was 
initially modelled by a single elastic-plastic material model that was representative of 
the mechanical properties of the material prior to the onset of corrosion. 
The loss of mechanical integrity due to the corrosion process, denoted by the 
damage parameter, D, was calculated on an element-by-element basis through a 
modified version of the damage evolution law described by Gastaldi et al (Gastaldi 
et al., 2011). The temporal value of the damage parameter, D, was calculated over a 
discrete volume of material governed by the element size, Le and, over a discrete 
time-step, ∆t. When Le and ∆t were sufficiently small; the damage parameter at a 
fixed time, De, was given by the relation: 
 
where  and Le were respective material and FE model characteristic lengths, in 
units of mm, and ku was a corrosion kinetic parameter, in units of h-1, as described 




Figure 3.8 Simplified flowchart of the corrosion model process 
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An element-specific dimensionless plastic strain parameter, φe, was 
introduced in this work in order to account for the effects of plastic strain-induced 
corrosion in the modelling framework. The value of φe for each element was 
dependent on both the magnitude of elemental εp1 and the simulated corrosion time, 
t, and was estimated from a table of values that were established in the 
experimental corrosion tests described in section 3.4.  
Depending on the number of element faces (NEF) that were exposed to the 
corrosion environment, the element damage calculated at each time step was 
modulated by an element-specific exposure parameter, κe. κe was a simple scaling 
parameter that was derived from a linear approximation of the slope of the curve 
that described the rate of diffusion through a brick element when NEF varied from 
one to six, as shown in Figure 3.9. κe was included in the modelling framework in an 
attempt to model the rounding of initially sharp strut corners which can be expected 
for a diffusion-dominated corrosion process (Ulvrová et al., 2012). 
 
Figure 3.9 The possible values for the element exposure parameter, κe, that were 
used to scale the element damage calculated at each time step 
When the damage parameter, D, reached or exceeded certain threshold 
values, the mechanical integrity of the element was reduced by modifying its 
 61 
 
material model. In this way, the gradual corrosion-induced reduction in the 
mechanical integrity of the elements was modelled. When the damage parameter 
reached a critical value (D=1), the element was assumed to have completely 
corroded and was eliminated from the model. The newly exposed element surface 
beneath the eliminated element became part of the exposed surface and was thus 
subject to corrosion in the next iteration of the model. The model iterated until the 
simulated corrosion time, t, reached the user-defined maximum solution time, tmax. 
3.5.1 Corrosion Model Calibration 
The corrosion model was calibrated based on the results of experiment A. As the 
corrosion-induced material loss observed in the experiments was relatively uniform 
in both the longitudinal and radial directions of the test region, repetitive and 
reflective symmetry simplifications were assumed and only a one-quarter slice of the 
dogbone specimen was modelled, as shown in Figure 3.10(a). A representation of 
the test region in the specimen, which was modelled as being flat rather than 
curved, was meshed with enhanced strain formulation brick elements, as shown in 
Figure 3.10(b). Symmetry boundary constraints were applied to the nodes on the 
two symmetry edges of the model. Nodes on the upper and lower surfaces of the 
model were constrained only in the direction of loading which permitted lateral 
constrictions as would be expected under uniaxial tensile loading. All nodes on the 
top surface were coupled in the direction of loading to a master node and a force 
was applied to this master node in order to simulate the tensile test. 
In representing the deformation of the material in the FE model, finite 
deformation kinematics was assumed. The initial mechanical properties were based 
on those of non-corroded WE43 dogbone specimens with 0% plastic strain, as 
determined from the uniaxial tensile tests described in section 3.4. Accordingly, 
elasticity was considered linear and isotropic in terms of finite deformation quantities 
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with E = 13 GPa. Material plasticity was described by a multi-linear isotropic 
hardening material model, in accordance with previous FE studies which used 
similar material models (Gastaldi et al., 2011; Wu et al., 2011), with σy = 160 MPa, 
UTS = 245 MPa and εu = 0.17. Poisson’s ratio had a value of 0.3 (Wu et al., 2010). 
 
Figure 3.10 (a) slice of dogbone specimen test region exhibiting repetitive and 
reflective symmetry (b) boundary and loading conditions used for the FE simulations 
The material properties of damaged elements were controlled through the 
evolution of the damage parameter, D. The corrosion-induced reduction in the 
mechanical integrity of the material, observed in the experiments, was characterised 
in the model by modifying the material model of the elements at certain threshold 
values of D. Ten material models were used to represent the material properties of 
elements with D values ranging from 0 to 1, in increments of 0.1, as shown in Figure 
3.11. For the stress-strain curves shown, it was assumed that the reduction in the 
load-bearing capacity of the element was directly proportional to the mass lost to 
corrosion. Therefore, the curves were produced by scaling the stress component of 
 63 
 
curve for the WE43 material by factors ranging from 0.9 to 0.1 in increments of 0.1.   
 
Figure 3.11 FE material model input used to represent the stress-strain properties of 
elements with D values ranging from 0 to 0.9 
Experiment A was modelled by simulating tensile loading and elastic recoil of 
the test region in order to induce the required magnitude of εp1 (0%, 2.7% and 
8.4%). Corrosion was then permitted to occur on exposed surfaces in the test 
region. The rate of mass loss over time was determined based on the average 
damage value (D) over all of the model elements. The maximum force withstood by 
the model was taken as a measure of loss in mechanical integrity. In calculating the 
stress-strain response of the model to tensile loading, the engineering stress was 
calculated based on the original cross-section of the specimen in order to facilitate 
comparison with the experimentally measured response.  
The material characteristic length, , was given a value of 0.015 mm, 
consistent with grain sizes observed in metallographic analysis of WE43 tubes. The 
slope of the mass loss curves from experiment A was used to generate a table of φe 
values for the three plastic strain magnitudes examined, as shown in Table 3.2. By 
interpolating between the data points in the table, a φe value was calculated for each 
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element based on the magnitude of εp1 in the element and simulated corrosion time. 
 
Table 3.2 The table of values established in experiment A from which the strain 
parameter, φe, was calculated in the FE corrosion model 
In calibrating the FE corrosion model, the values of the independent model 
parameters ku, Le and ∆t were determined for given values of , φe and κe, based on 
the simulation of experiment A. These values were determined by imposing three 
conditions. First, the predicted temporal mass loss curves should match that 
observed in experiment A. Second, the simulated corrosion-induced reduction in 
specimen mechanical integrity should match that observed experimentally. Third, 
the model should predict the corrosion rates observed in experiment A, thus 
allowing the parameter kU to be determined. These conditions allowed the 
determination of suitable element length (Le = 0.012 mm) and time step (∆t = 1 h) 
values through an iterative calibration process, as shown in the convergence study 
in Appendix A.4.1. 
In order to validate the predictive capabilities of the corrosion model for the 
calibrated parameters, the corrosion of the dogbone specimens observed in 
experiment A was simulated. Loading and elastic recoil of the sample in uniaxial 
tension was simulated followed by the subsequent corrosion of the specimen under 
the influence of 0%, 2.7% and 8.4% plastic strain. Model predictions were compared 
to the experimental results. 
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3.5.2 Stent Model 
The calibrated corrosion model was used to predict the corrosion performance of the 
absorbable magnesium stent. The design and geometry of the stent were taken 
directly from the experiments, as shown in Figure 3.12(a). The stent geometry, 
which exhibited rotational and circumferential symmetry, as well as periodicity in the 
longitudinal direction, was represented by a repeating unit cell (RUC) model that 
was meshed with 91,320 brick elements, as shown in Figure 3.12(b). The RUC 
method is an established technique which can be used to reduce model size and 
solution time in the numerical analysis of models balloon-expandable stents (Ju et 
al., 2008; Li et al., 2009; Xia et al., 2007). The element type and material models 
used for the stent were the same as those described earlier for the dogbone 
specimen model in section 3.5.1. 
In order to reduce the computational cost of modelling the interaction of the 
balloon and stent, spring elements were incorporated to simulate the constraint of 
the balloon using an established technique (Early et al., 2009; Zahedmanesh et al., 
2010). The springs had multi-linear stiffness and were attached to the nodes on the 
inner surface of the stent. The springs had low stiffness (1 x 10-7 N/m) until the stent 
reached nominal diameter at which point the stiffness increased sharply (0.1 N/m) to 
inhibit further stent expansion. Periodic boundary conditions were imposed on the 
symmetry planes of the unit cell in the rotational and longitudinal directions using 
nodal displacement constraint equations, as outlined in (Xia et al., 2007). A suitable 
average element size (Le = 0.012mm) and time step (∆t = 1 hour) was established by 
means of a convergence study in which predicted nodal displacement, element 
stress and strain, mass loss and stent radial stiffness results were all converged to 
within 2%, as shown in Appendix A.4.2.  Based on the selected Le, the corrosion 
model parameters were scaled accordingly. Stent material properties were taken to 




Figure 3.12 (a) Image of the full stent geometry with a repeating unit cell (RUC) 
indicated (b) The geometry  of the FE RUC model prior to deployment (c) Loading 
applied to contact elements in order to predict the radial stiffness of the stent 
The deployment of the uncrimped stent, by way of free expansion, was 
simulated through the application of a uniform linearly-increasing radial pressure at 
the internal surface of the stent. When the outer diameter of the stent reached a 
value similar to that measured experimentally, the pressure load was reduced to 
zero in order to simulate elastic recoil. The rate of mass loss was determined based 
on the average damage value (D) over all of the model elements. At 20 hour 
intervals of simulated corrosion time, a flat analytical surface comprising of contact 
elements, was brought into contact with the outer surface of the stent and was used 
to compress the stent in the same manner as that used in the experiments, as 
shown in Figure 3.12(c). Again, the radial stiffness of the stent was calculated as the 
change in resistive force for an applied 10% reduction in stent diameter. 
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Stent Model Calibration 
Based on the mass loss curves obtained experimentally for plastic strain values of 
0%, 2.7% and 8.4%, the corrosion model predicted the value of φe for each element 
by interpolating, for the εp1 value in the element, between the data points of the 
experimental curves. However, preliminary stent deployment simulations showed 
that a small proportion of the elements (typically less than 4%) had εp1 values, 
ranging from 8.4% to 27%, that were outside the range measured experimentally, as 
shown in the distribution plot in Figure 3.13(a). In order to investigate the 
relationship between εp1 and φe for these elements, two different corrosion models 
were developed. In the linear plastic strain (PS) corrosion model, a linear 
relationship was assumed between εp1 and φe above εp1 values of 8.4%. In the plastic 
strain corrosion model, a non-linear relationship was assumed, where φe increased 
sharply for elements with εp1 values above 8.4%; with substantially higher φe applied 
when εp1 exceeded the engineering strain observed experimentally at the UTS 
(~20%). For both models, the results predicted for mass loss and radial stiffness 
were compared to the experimental data in order to determine the model that gave 
the best correlation. 
 
Figure 3.13 (a) Distribution of the elemental εp1 values for the stent model (b) Linear 




4.1 Stent Manufacture 
4.1.1 Laser Cutting 
Laser cutting of WE43 tubes produced parts with substantial dross and spatter 
attachment (see Figure 3.2). Dross may form during laser cutting when a significant 
temperature gradient exists between the top and bottom surface of the work-piece. 
This results in a greater amount of material being melted on the underside of the 
work-piece. The low viscosity and low surface tension of melted magnesium also 
may have contributed to the spatter attachment observed. Excessive amounts of 
dross and spatter attachment on the inner surface of the tube prevented the normal 
fallout of cut sections. Therefore, machining parameters were optimised for cutting 
the material including the laser power, pulse repetition frequency, pulse width, laser 
wavelength and cutting speed, as shown in Table 4.1. 
 
Table 4.1 Optimised laser machining parameters for cutting WE43 tube  
Nitrogen was selected as an inert shield gas in order to minimise oxidation 
and gas pressure was increased to improve the quality of the cut and to reduce 
dross accumulation. The focal position of the laser beam was adjusted to increase 
the kerf width and hence aid fallout of cut sections. Optimisation of laser parameters 
successfully reduced dross and spatter adherence. The remaining dross was 
removed by a combination of chemical and plasma etching processes. 
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4.1.2 Chemical and Plasma Etching 
There was an observable difference in the surface texture of inner and outer 
surfaces which appeared to originate from the extrusion process used to produce 
the tubes. Outer surfaces had the smoothest appearance while inner surfaces 
appeared marginally rougher. Surfaces produced by laser cutting had the roughest 
appearance. Chemical etching with phosphoric acid removed bulk dross and surface 
scale from all stent surfaces. A layer of material measuring approximately 5 µm was 
removed, as measured under SEM. The texture of all stent surfaces was 
significantly improved to a more uniform morphology, as shown in Figure 4.1. 
Significant variation was evident in the surface texture of inner, outer and laser cut 
surfaces after chemical etching. A significant amount of residue and contamination 
remained on the stent surfaces following the chemical etching process, as shown in 
Figure 4.1. 
 
Figure 4.1 Stent surfaces resulting from chemical etching: (a) outer stent surface 
with residue (dark areas), and (b) inner surface of stent strut 
Plasma etching and cleaning was employed in order to remove the surface 
deposits and contamination that remained from the chemical etching process. SEM 
and photographic images of a finished stent are shown in Figure 4.2 and Figure 4.3, 
respectively.  It can be seen that plasma etched surfaces appeared lighter in colour 
compared to chemically etched surfaces and residues were completely removed. 
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Plasma processing reduced surface roughness of all surfaces compared to 
chemically etched surfaces. The plasma etching process was most effective on the 
outer surface and less effective on shadowed surfaces and laser cut edges, as 
shown in Figure 4.2. Plasma etching was performed in three stages where the 
specimens were manually rotated in increments of 120° on the quartz plate in order 
to minimise shadowing effects. Although RIE acts mainly as a “line-of-sight” 
process, it is likely that a significant number of ions would have reached the inner 
stent surfaces owing to the small strut width (120 µm), the comparatively large 
spacing between the struts, and the high sheath potential (~495 V). The specimen 
rotation technique employed here would have limited efficacy in reducing the 
shadowing effects. A planetary rotating system would provide a more effective 
method to minimise shadowing effects through continuous specimen rotation during 
plasma processing. 
The etch rate of the 90% Ar and 10% O2 plasma process was not measured 
as it was beyond the scope of this work. However, one would expect a significantly 
higher etch rate for the WE43 alloy when compared to relatively harder traditional 
stent materials such as stainless steel (316L), cobalt-chromium alloys and titanium 
alloys. Etch rates of 20 to 30 nm/min in 100% Ar plasma have been reported for 
pure magnesium (Nishimoto, 2003) and MgO thin films (Kim and Kim, 2007). These 
studies used higher power settings (300 - 500 W) and higher proportions of Ar 
compared to those used in this work. The use of comparatively lower power settings 
and a lower proportion of Ar in this study suggest etch rates well below 20 nm/min 
for the WE43 alloy material. Therefore, one may expect that a layer of material no 





Figure 4.2 SEM images of a finished stent following plasma etching and cleaning: 
(a) stent mounted on fused silica tube, (b) inner surface, and (c) outer surface 
 




4.1.3 Surface Characterisation 
Surface Chemistry 
Figure 4.4(a) shows that the as-received specimens had a relatively rough surface 
morphology that consisted mainly of a dark-coloured magnesium (Mg) matrix area 
(α-phase)  interspersed with lighter-coloured β-phase areas (Hänzi et al., 2009). The 
chemical compositions of both the α-phase and β-phase regions of the specimen 
were measured by EDX at three different sites. Figure 4.4(a) shows the sites where 
spectra were taken for α-phase (S1-S3) and β-phase (S4-S6) measurements. The 
weight percent (%) of each element detected at the three sites was averaged 
(mean) in order to produce the plot shown in Figure 4.4(b). The error bars were 
calculated as the standard deviation in order to represent the overall distribution of 
the data. It should be noted that, as with many EDX systems, the system used in 
this work had inherent difficulty measuring light elements owing to low fluorescence 
yield, absorption and peak overlaps with heavier elements (Berlin, 2011). Therefore, 
the readings for C and O obtained by EDX in this work should be disregarded. 
 
Figure 4.4 (a) Typical surface morphology of as-received specimen showing spectra 
sites S1-S6, and (b) average chemical composition at spectra sites S1-S3 and 
spectra sites S3-S6 
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EDX analysis confirmed the α-phase had high concentrations of Mg (62%) 
and low concentrations of distributed alloying elements Y (5.6%), Nd (6.2%) and Zr 
(1.0%) along with O2 (19.4%) and C (6.1%). Conversely, the surface of the 
secondary phase areas had low Mg (16.7%) and relatively higher concentrations of 
alloying elements Y (19.6%), Nd (30.3%) and Zr (1.3%) along with O2 (28.3%) and 
C (4.0%). A detailed characterisation of the microstructure of a similar wrought 
WE43 alloy is given in (Coy et al., 2010). 
Chemical etching in phosphoric acid resulted in significant changes in the 
appearance and surface chemistry of the specimens. The native oxide layer was 
replaced with a more passive oxide layer with lower porosity and increased 
corrosion resistance. The surface morphology was more homogenous owing to the 
lower porosity of the new oxide layer, as shown in Figure 4.5(a). EDX analysis 
showed that the new surface layer consisted of Mg (91.3%), Y (0.8%), Zr (0.1%), O2 
(6.0%) and C (0.6%) and small amounts of Na (1.0%) and P (0.1% – 0.85%). It is 
believed that the presence of P in the surface layer can be attributed to the 
formation of magnesium phosphate during etching (Gray-Munro et al., 2009). The 
presence of Na in the surface layer may be attributed to the formation of a thin layer 
of sodium hydroxide that is adsorbed to the specimen during the neutralisation 
treatment.  
A number of rectangular-shaped entities were distributed within the surface 
layer of the chemically etched specimens, as shown in Figure 4.5(a). An EDX 
spectrum at S2 showed that these entities were rich in the RE elements Y (80.3%), 
Nd (9.9%) and Zr (0.8%). The dark surface deposits shown in Figure 4.5(b) 
consisted mainly of O2 (46-48%), Na (19.7-28.5%), P (18-25.1%) and Mg (1-10%). 
These heavy deposits were likely to have been oxides with P and NaOH content as 




Figure 4.5 Typical surface morphology of chemically etched specimen: (a) normal 
surface appearance, (b) dark area with surface residue, and (c) chemical 
composition of surface at spectra sites S1-S4 
Plasma etching successfully removed unwanted surface deposits and 
residue, as shown in Figure 4.6(a). EDX analysis showed lower concentrations of P 
and Na on plasma etched surfaces compared to chemically etched surfaces, as 
shown in Figure 4.6(b). These results suggest that the heavy Ar ions in the plasma 
may have removed some of the phosphor-rich coating. The amount of material 
removed from the surface can easily be reduced by shortening the treatment time or 




Figure 4.6 (a) Typical surface morphology of plasma etched specimen showing EDX 
spectra sites S1-S6, and (b) average chemical composition of surface at spectra 
sites S1-S6 
Surface Roughness 
Figure 4.7 shows the surface morphologies measured by AFM for the as-received, 
chemically etched and plasma etched specimens. Figure 4.8 shows average surface 
roughness values (Sa) for the same three specimen conditions. It was found that 
plasma etched specimens had the lowest surface roughness (172 nm) compared to 
chemically etched (191 nm) and as-received (223 nm) specimens. A one-way 
analysis of variance (ANOVA) showed that the mean surface roughness amongst 
the three specimen groups (as-received, chemically etched and plasma etched) was 




Figure 4.7 Typical surface morphology of specimens generated by AFM: (a) as-
received, (b) chemically etched, and (c) plasma etched 
 
Figure 4.8 Surface roughness (Sa) values (mean ± standard deviation) measured by 
AFM for as-received, chemically etched and plasma etched tube specimens 
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The tubes used in this work were subjected to an annealing process. The 
average surface roughness (Sa) was relatively high in the as-received condition 
owing to the non-uniform morphology during the tube extrusion process. Figure 
4.9(a) shows the parallel lines and defects that ran longitudinally on the surface 
indicating the direction of the tube extrusion process. These defects were potential 
sites of stress concentration and material failure due to crack growth during stent 
expansion. The chemical and plasma processing steps ware intended to minimise 
these defects. The surface texture was considerably improved by chemical etching 
which reduced the Sa value by 14.7% from 223 nm to 191 nm. No surface defects 
were evident on the surface layer that was produced by chemical etching, as shown 
in Figure 4.9(b). The plasma etched surface was considerably brighter in 
appearance compared to the surfaces of the other two specimens, as shown in 
Figure 4.9(c). The average surface roughness of plasma treated specimens (172 
nm) was 10% lower compared to chemically etched specimens (191 nm). 
 
Figure 4.9 SEM images of tube specimens: (a) as-received, (b) chemically etched, 
and (c) plasma etched and cleaned (magnification = 1000x) 
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4.2 Mechanical Testing 
In the first test, free expansion of the WE43 stent occurred mainly between balloon 
pressures of 1 atm and 3 atm, while the equivalent range for the 316L stent was 
between 2 atm and 6 atm, as shown in Figure 4.10(a). Owing to high stent 
compliance, the proximal and distal ends of the WE43 stent flared significantly at 
low balloon pressure thus contributing to the rapid increase in ID observed. At the 
maximum balloon pressure of 15 atm, the average ID for WE43 (4.01 mm) was 9% 
greater than for 316L (3.68 mm). The inset in Figure 4.10(a) shows the typical 
deformed geometry of a WE43 stent at three different phases of the free expansion 
procedure, namely: unexpanded, fully expanded and after elastic recoil. ERR for 
WE43 (4.4%) was higher compared to the 316L stent (3.6%), as shown in Figure 
4.10(b). FS was significantly lower for WE43 (0.84%) compared to 316L (3.55%). 
Negative DB was greater for WE43 (-2.4%) compared to 316L (-0.52%), thereby 
indicating a larger central ID than distal ID at maximum balloon pressure, for both 
stent types. 
In the second test, WE43 and 316L stents were expanded inside MCAs, as 
shown in Figure 4.10(c). Stent metrics were calculated based on measurements of 
MCA OD as the stent ID could not be accurately measured by visualisation. 
Compared to free expansion results in the first test, higher ERR and lower DB 
values were recorded for both stent types, as shown in Figure 4.10(b), owing to the 
presence of the MCA which applied an inward-acting radial force to the stent. 
Compared to the first test, FS values were higher for WE43 and lower for 316L 
stents when deployed in MCAs.  
In the third test, under the influence of sequential static physiological 
pressure loads (80 & 120 mm Hg), the MCA that was stented with a WE43 stent 
exhibited a cyclic strain amplitude (0.72 %) that was approximately 2.5 times greater 
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than for the 316L stented MCA (0.29%), as shown in Figure 4.10(d). This finding 
suggested that the MCA exhibited significantly greater compliance when stented 
with the WE43 stent compared to the 316L stent. 
The surfaces of deployed stents were examined by SEM and there was no 
evidence of strut failure or cracking, as shown in Figure 4.11(d).  
 
Figure 4.10 (a) Pressure-diameter curves for freely expanded stents. Inset: WE43 
stent shown unexpanded, fully expanded and after recoil, (b) performance metrics 
for the free expansion and expansion in MCA of stents, (c) WE43 stent (top) and 
316L stent (bottom) and (d) cyclic strain amplitude results. Error bars represent one 




Figure 4.11 Expansion testing of WE43 stent: (a) unexpanded, (b) fully expanded (c) 
after recoil (d) SEM image of a strut section from an expanded stent 
4.3 Corrosion Experiments 
Based on the results of experiment A, the mass lost over time by the three groups of 
dogbone specimen is shown in Figure 4.12. It can be seen that the rate of mass loss 
increased for specimens with greater levels of plastic strain. Specimens with 0% 
plastic strain exhibited a relatively low rate of mass loss for the first 1 d of 
immersion; however, it increased thereafter to give a steady rate of mass loss from 
which an average corrosion rate of 0.021 mg cm-2 h-1 was derived. For specimens 
with plastic strain, higher rates of mass loss were observed for the first 1 d 
immersion, which slowed significantly between 2 d and 4 d. Beyond 4 d, specimens 
with 2.7% and 8.4% plastic strain exhibited relatively stable rates of mass loss from 
which average corrosion rates of 0.025 mg cm-2 h-1 and 0.027 mg cm-2 h-1 were 
derived, respectively. 
SEM images, displaying typical surfaces on the inner walls of dogbone 
specimens with 0% plastic strain, are shown in Figure 4.13. The surface morphology 
produced by the surface treatments on a finished specimen, prior to immersion 
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testing, is shown in Figure 4.13(a). It can be seen that the magnesium matrix 
material was uniformly removed by chemical etching but some intermetallic 
precipitates were visible in the surface layer. After 1 d immersion, microscopic pits 
were observed on this surface layer, as shown in Figure 4.13(b). Wide, shallow 
corrosion pits, surrounded by elevated regions of darker material, were observed on 
the surface after 3 d immersion, as shown in Figure 4.13(c). The pits increased in 
size and number over time and thus coalesced and advanced over large regions of 
the surface, as shown in Figure 4.13(d). 
 
Figure 4.12 Plot of percentage mass lost over time by dogbone specimens based on 
the results of experiment A. Error bars represent a single standard deviation from 
the mean. 
The composition of the material in the corrosion pits, as determined by EDX 
analysis, was consistent with that of the magnesium matrix of the alloy. The 
elevated regions were rich in RE elements (Zr, Y and Nd) and had compositions that 
were consistent with the β-phase and other intermetallic compounds for the WE43 
alloy. Pitting corrosion of the magnesium matrix, at the interface with the β-phase, 
 82 
 
led to the undermining and fall-out of β-phase particles, as shown in Figure 4.13(e). 
Corrosion attack was observed to progress in a layer by layer manner and thus, a 
relatively uniform specimen morphology resulted after 10 d immersion, as shown in 
Figure 4.13(f). When the inner and outer walls of the specimen were compared, 
corrosion attack on laser cut edges resulted in a different morphology, as shown in 
Figure 4.13(g). 
 
Figure 4.13 SEM images of dogbone specimens with 0% PS following immersion in 
solution for (a) 0 d, (b) 1 d, (c) 3 d, (d) 3 d (e) 10 d, (f) 10 d and, (g) 10 d 
The corrosion processes observed for specimens with plastic strain was 
similar to that described above for specimens with 0% plastic strain. However, 
specimens with plastic strain exhibited significantly more advanced pitting corrosion 
attack after just 1 d, and some cracks were observed, as shown in Figure 4.14(a). 
Further, the corrosion layer on these specimens displayed many cracks and had a 
significantly rougher appearance, as shown in Figure 4.14(b). As a result, pitting 
corrosion of the magnesium matrix and the undermining of β-phase particles 
progressed at an accelerated rate, as shown in Figure 4.14(c). Compared to 0% 
plastic strain specimens, corrosion attack after 10 d immersion was greater for 
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specimens with 2.7% plastic strain, as shown in Figure 4.14(d) and significantly 
greater for specimens with 8.4% plastic strain, as shown in Figure 4.14(e). 
Corrosion attack on the laser cut edges was also more pronounced for specimens 
with plastic strain. This may be attributed to a number of influences at the specimen 
edge surfaces such as deformation-induced residual stresses and the influence of 
processing (laser cutting and surface treatments) on the composition, microstructure 
and crystallographic orientation of the material. 
 
Figure 4.14 SEM images of dogbone specimens with 2.7% PS following immersion 
in solution: (a) 1 d, (b) 6 d, (c) 10 d, (d)  10 d and, (e) 10 d (8.4%PS) 
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Based on the SEM images and the uniform nature of the corrosion observed, 
it is suggested that localised micro-galvanic corrosion may be the dominant 
corrosion processes in this case. The differences in the surface morphology and 
mass loss rates for specimens with plastic strain suggests that plastic strain had a 
significant influence on the corrosion behaviour. Plastic strain likely resulted in 
significant damage to the brittle surface oxide thus allowing corrosion attack to occur 
immediately after immersion in the solution and to progress at an accelerated rate. 
The cracking observed on the surface might be attributed to material damage 
induced by the application of plastic strain, and the influence of hydrogen 
embrittlement and SCC. The application of plastic also likely led to deformation-
induced acceleration in galvanic corrosion processes within the alloy. 
Stress-strain curves with error bars representing 95% confidence intervals 
are shown in Appendix A.2 for specimens with 0%, 2.7% and 8.4% plastic strain. 
For simplicity, representative stress-strain curves are shown in Figure 4.15(a-c) for 
specimens with 0%, 2.7% and 8.4% plastic strain, respectively. Specimen strength, 
as determined by dividing the maximum load withstood by the specimen in tension 
by the original specimen cross-sectional area, was seen to decrease significantly for 
both immersion time and increasing plastic strain, as shown in Figure 4.15(d). 
Similarly, there was a consistent reduction observed in E, σy and εu for increasing 
immersion time and for increasing plastic strain, as shown in Figure 4.15(e-g). The 
plastic strain induced prior to corrosion testing led to work-hardening and hence an 
increase in the initial σy of the 2.7% and 8.4% plastic strain specimen series which 




Figure 4.15 Representative stress-strain curves for dogbone specimens based on 
the results of experiment A, (a) 0% PS (b) 2.7% PS and (c) 8.4% PS. Mechanical 
properties of dogbone specimens over time: (d) UTS, (e) εu, (f) E and (g) σy. Error 
bars represent one standard deviation of uncertainty. 
SEM images of fractured dogbone specimens following tensile testing are 
shown in Figure 4.16 (a-d). It can be seen that, compared to the non-corroded 





Figure 4.16 SEM images of typical fractured dogbone specimens after tensile 
testing: (a) 0% PS and 0 d (i.e. no corrosion), (b) 0% PS and 10 d (c) 2.7% PS and 
10 d, (d) 8.4% PS and 10 d immersion 
Typical fracture surfaces for specimens are shown in Figure 4.17. Non-
corroded specimens with 0% plastic strain presented dimple (ductile) rupture, as 
shown in Figure 4.17(a). After 10 d immersion, specimens with 0% plastic strain 
displayed corrosion pits along with ductile features on the non-corroded cross-
section, as shown in Figure 4.17(b).  After 10 d immersion, specimens with plastic 
strain (2.7% and 8.4%) exhibited relatively greater pitting corrosion along with 





Figure 4.17 Typical morphology of the fracture surfaces of dogbone specimens after 
tensile testing (a) 0% PS and 0 d – dimple rupture, (b) 0% PS and 10 d – corrosion 
pits with ductile features on non-corroded cross section (c) 2.7% PS and 10 d – 
predominant intergranular cracking with brittle features and some transgranular 
(arrow) cracking, (d) 8.4% PS and 10 d corrosion - predominant intergranular 
cracking with brittle features and some transgranular (arrow) cracking 
Based on the results of experiment B, the percentage mass lost over time by 
freely expanded WE43 stents, as shown in Figure 4.18(a), was relatively high for the 
first 10 h but decreased significantly between 10 h and 30 h. Beyond 30 h, the rate 
of mass loss was largely steady from which an average corrosion rate of 0.021 mg 
cm-2 h-1 was derived. The initial and steady state mass loss per unit area, observed 
for the stent was greater than that observed for dogbone specimens with 0% PS, as 
shown in Figure 4.18(b). Further, the shape of the curve for the stent was similar to 
that for dogbone specimens with plastic strain in experiment A; suggesting that the 
elevated rate of mass loss observed for the stent, may be attributed to the influence 
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of the plastic strain. The average strut width, in the longitudinal direction, decreased 
with immersion time for the stent, as shown in Figure 4.18(c), to a final value of 103 
m after 60 h. 
 
Figure 4.18 Results plots for experiment B (a) Percentage mass lost over time for 
stent, (b) Mass loss per unit area for stent and dogbone specimens (c) Plot of 
average strut width over time for stent. Error bars represent a single standard 
deviation from the mean 
Images of the typical corrosion surfaces of the stent are shown in Figure 
4.19(a-d). The liberation of H2 gas bubbles into the solution, which indicated 
corrosion activity, was visualised using phase contrast microscopy for a number of 
stents and, was more pronounced at plastic hinge regions after 3 h immersion, as 
shown in Figure 4.19(a). After 20 h, the stent surfaces were rougher in appearance 
owing to preferential pitting corrosion of the magnesium matrix, as shown in Figure 
4.19(b). A significant amount of material was corroded from the stent surface due to 
the localised micro-galvanic attack after 40 h, as shown in Figure 4.19(c). The 
morphology of stent struts after 60 h immersion is shown in Figure 4.19(d). It can be 
seen that increased localised corrosion attack occurred at regions of the stent that 
experienced high plastic strain during the deployment procedure, as indicated by the 
arrows. Representative force-compression curves, derived from radial stiffness tests 
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performed on stents, are shown in Figure 4.19(e). The radial stiffness was 
significantly lower for the WE43 stent compared to the 316L stent. The radial 
stiffness of the WE43 stent decreased significantly with immersion time, as shown in 
Figure 4.19(f), with a loss of 46 % in radial stiffness after 60 h immersion. 
 
Figure 4.19 Typical morphology of a stent section after an immersion time of (a) 3 h, 
(b) 20 h, (c) 40 h & (d) 60 h. (e) Representative force versus compression curves for 
the WE43 and 316L stent (error bars omitted for clarity), (f) Temporal radial stiffness 
of WE43 stent. Error bars represent a single standard deviation from the mean 
4.4 Corrosion Modelling 
4.4.1 Corrosion Model Calibration 
Three simulations were performed using the corrosion model in order to predict the 
corrosion behaviour of the dogbone test section for induced plastic strain values of 
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0%, 2.7% and 8.4%. A uniform plastic strain state was predicted in all simulations 
thereby confirming that suitable boundary conditions and loading were used for the 
model. Corrosion was simulated by the progression of the damage parameter, D, 
and the removal of elements from the FE mesh. The progression of D for the case of 
a dogbone model with 0% plastic strain is shown in Figure 4.20. 
 
Figure 4.20 Damage parameter (D) values predicted by the corrosion model at 48 h 
intervals for a specimen with 0% plastic strain 
The parameters for the corrosion model, which were calibrated based on the 
results of experiments A, are shown in Table 4.2. Parameters are shown for two 
cases, that of an idealised uniform corrosion model and that of the plastic strain 
model that most closely captured the experimentally observed corrosion behaviour. 
The calibrated rate of mass loss from the corrosion model was compared to that 
observed experimentally in Figure 4.21. It can be seen that the plastic strain model 
was capable of capturing the experimentally observed rate of mass loss over time 
for the three investigated values of plastic strain. However, the mass loss over time 
predicted by the uniform corrosion model showed only moderate correlation with 
that observed experimentally. 
 




Figure 4.21 Predicted mass loss from the calibrated corrosion model compared to 
that observed experimentally 
The plastic strain corrosion model was further able to capture the 
experimentally observed specimen stress-strain response and, the non-linear 
corrosion-induced reduction in specimen mechanical integrity, as shown in Figure 
4.22, whereas the uniform model failed to predict the experimentally observed trend, 
as shown in Figure 4.23. 
 
Figure 4.22 Predicted specimen stress-strain response over time for the plastic 
strain corrosion model compared to that observed experimentally for plastic strains 




Figure 4.23 Predicted specimen stress-strain response over time for the uniform 
corrosion model compared to that observed experimentally for plastic strains of (a) 
0%, (b) 2.7% and (c) 8.4% 
4.4.2 Stent Model 
The simulated free expansion and recoil of the RUC stent model is shown in Figure 
4.24(a) and (b), respectively. It can be seen that the predicted magnitude of εp1 
varied from 0% to 27% for the deployed model. The stent outer diameters pre- and 
post-recoil were 4.3 mm and 3.9 mm, respectively. Following expansion and recoil, 
the corrosion of the stent was simulated using the plastic strain corrosion model, the 
linear plastic strain corrosion model and the uniform corrosion model, as shown in 
Figure 4.25(a-c), respectively. It can be seen that the predicted corrosion attack led 
to a non-uniform degradation in the stent geometry for all three corrosion models, 
with the largest amount of corrosion attack predicted at the plastic hinge regions of 
the stent. Compared to the other corrosion models, the plastic strain corrosion 
model predicted the greatest corrosion attack at the plastic hinge regions, as shown 




Figure 4.24 Simulated deployment of the RUC stent model: (a) fully expanded (b) 
predicted εp1 post recoil 
 
Figure 4.25 Predicted corrosion damage (D) after an immersion time of 10 hours (a) 




The plastic strain corrosion model predicted the greatest stent mass loss 
over time and best characterised that observed experimentally, when compared to 
the other corrosion models, as shown in Figure 4.26. 
 
Figure 4.26 Predicted mass loss for the stent over time 
The plastic strain corrosion model was further able to predict the influence of 
plastic strain on the stent radial stiffness both quantitatively and qualitatively, while 
the other two corrosion models failed to describe the non-linear relationship, as 
shown in Figure 4.27(a). The force compression curves predicted by the plastic 
strain corrosion model were in good agreement with those observed experimentally, 
as shown in Figure 4.27(b). 
The plastic strain corrosion model was used to predict the influence of three 
different values of stent expansion ratio (SER) on the performance of the stent. It 
was found that higher values of SER led to significant increases in the predicted 
stent mass loss and in the temporal corrosion induced loss of radial stiffness for the 




Figure 4.27 (a) Predicted stent radial stiffness at 10% compression (b) Predicted 
stent radial force versus percentage compression over time 
 
Figure 4.28 (a) Predicted stent mass loss for different values of stent expansion ratio 








5.1 Stent Manufacture 
Magnesium alloys possess many inherent characteristics that render them difficult to 
cut by laser (Abderrazak et al., 2009). The use of an inert nitrogen shield gas, 
appropriate laser cutting parameters and suitable surface treatments greatly 
reduced the effects of the HAZ produced by laser cutting. Machining parameters 
were optimised for the WE43 material in order to produce consistent strut 
geometries and clean cuts with minimal dross and spatter adherence. This enabled 
the normal fallout of waste sections from the machined stents. 
Chemical etching provided a simple and inexpensive surface treatment 
which removed dross and spatter remaining from laser cutting, improved surface 
finish, imparted a non-toxic biocompatible phosphor-rich corrosion-resistant layer 
and provided a coating pre-treatment in order to functionalise the stent surface. 
SEM, AFM and EDX studies showed that plasma etching and cleaning in a 
mixture of Ar-O2 gas plasma and pure O2 plasma successfully reduced surface 
roughness by 10% compared to chemically etched surfaces and completely 
removed surface contaminants remaining from the chemical etch process. Plasma 
processing yielded improvements in biocompatibility through increased surface 
sterility and wettability (Yi et al., 2004) and, also enhanced the surface adhesion 
properties for subsequently deposited coating (Nakamura et al., 1996). 
The combination of chemical and plasma etching surface treatments 
produced stent surfaces with low roughness which have been associated with 
decreased thrombogenicity and IH formation (De Scheerder et al., 2001) and 
reductions in ISR in porcine models (Halwani et al., 2010). Also, the pitting tendency 
and corrosion rate are reduced with decreasing surface roughness for magnesium 
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alloys (Walter and Kannan, 2010) thus, permitting the mechanical integrity of the 
device to be maintained for a longer period of time.  
The suitability of the processing route used in the manufacture of the 
magnesium stent was confirmed in deployment testing where all stents were 
expanded successfully and exhibited a uniform deployed geometry. During stent 
deployment, the elevated strain levels that are induced at plastic hinge sites may 
induce micro-cracks and other defects in poorly processed stents. Such defects can 
propagate through the material leading to strut fracture which may contribute to 
overall device failure and has been associated with higher rates of focal ISR (Celik 
et al., 2008; Sianos et al., 2004). In this study, stents were deployed with no 
cracking or fractures observed under SEM (Figure 4.11). 
It should be acknowledged that cracks in the surface oxide layer are difficult 
to detect in post-deployment analysis (i.e. under SEM) as they are likely to close 
upon balloon deflation. Also, magnesium has high affinity to oxygen and therefore a 
new surface oxide is likely to quickly form over cracks and other defects making 
their detection difficult. Sub-surface defects would likely become evident with the 
progression of corrosion in the substrate, though no evidence of this was observed 
in the experiments. Non-destructive test (NDT) methods such as ultrasonic testing, 
eddy current or phased array could be used to determine the severity of the material 
damage induced in the struts by the stent deployment process. 
5.2 Mechanical Testing 
The ability of the WE43 stent to deploy at low balloon pressures, compared to 
commercial 316L stents (Figure 4.10(a)) could potentially be beneficial in terms of 
reducing arterial injury and hence ISR in arteries with low to moderate levels of 
disease where predilation of stenosis is not required. Although it has been shown 
that IH is not significantly greater after high pressure implantation of traditional BMS 
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compared to low pressure implantation (Hoffmann et al., 2001); no such 
investigation has been carried out for bare-metal or drug-eluting magnesium stent 
platforms. Lower radial stiffness and higher elastic recoil were observed for the 
WE43 stent, compared to the 316L stent, in the deployment experiments (Figure 
4.10(b)). Elastic recoil of a stent permits an immediate re-narrowing of the stented 
artery upon balloon deflation and represents a negative clinical result. The relatively 
high elastic recoil observed in this work for the WE43 stent in the MCA may be 
attributed to the influences of the stent geometry, the relatively low elastic modulus 
of WE43 and the moderate SER used in the experiments. These findings are in 
agreement with those reported in clinical trials of the Biotronik Magic stent (AMS-1), 
where post-dilation was frequently used to obtain larger lumen diameter, owing to 
the relatively low radial stiffness and high acute recoil of the stent (Erbel et al., 
2007). Later versions of the Biotronik DREAMS stent used a non-commercial form 
of the WE43 alloy and had a revised stent geometry that reduced elastic recoil 
below 3% (Waksman, 2011).  
Post-dilation and over-expansion presents a greater fracture risk for 
magnesium stents compared to stents manufactured from traditional materials, such 
as 316L, due to the increased likelihood of localised material fracture in magnesium 
alloys (Grogan et al., 2012; Poncin and Proft, 2003). In this study, trial deployment 
tests were carried out to investigate the risk of fracture for the magnesium stent. 
Stents were deployed using both 3.5 mm and 4.0 mm angioplasty balloons, 
representing SERs of 2.05 and 2.3, respectively. SEM analysis revealed a number 
of fractured struts for a SER of 2.3. In all cases, the stent successfully expanded to 
a SER of 2.05 (Figure 4.11(a)), with no fractures observed, which compared 
favourably to the SER (1.5) observed for crimped AZ31 stents in a similar study, 
where some strut fractures were reported (Wu et al., 2012). Therefore, all the 
subsequent deployment testing carried out in this study used 3.5 mm angioplasty 
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balloons, as described in section 3.3. 
In the third test (cyclic strain amplitude), prior to the application of the static 
pressure loads, the elastomeric MCA acted to reduce the diameter of the stent that 
was deployed within it. Under the influence of physiological pressure loads, the 
diameter of both the MCA and the stent were observed to increase. It was noted that 
contact was maintained at all times during the tests between the outer stent surface 
and the inner MCA surface. In mechanics therefore, the stented MCA construct 
could be represented by two springs of different stiffness connected in series. The 
stent was significantly stiffer and likely followed a near-linear pressure-displacement 
curve under physiological pressure loads. The MCA was significantly more 
compliant and exhibited a non-linear hyperelastic response under pressure loads in 
the physiological range (Colombo et al., 2010). Significantly higher cyclic strain 
amplitude levels were observed for MCAs stented with the WE43 stent, compared to 
the 316L stent (Figure 4.10(d)). This may be attributed to the influence of the lower 
elastic modulus of WE43 compared to 316L and the significant differences that 
existed in the geometrical design of the two stents. The WE43 stent had a greater 
inner surface area, compared to the 316L stent, upon which static pressure acted to 
deform the stent radially. This may have contributed to the higher cyclic strain 
amplitude levels observed for the WE43 stent. Another limitation of the test was the 
inability of the videoextensometer to measure the ID or OD of the stent directly by 
visualisation due to the opacity of the MCA material. Therefore changes in the 
diameter of the stent (and hence cyclic strain amplitude) were inferred from 
measurements of the MCA OD which was not ideal. Small measurement errors in 
the apparent stent OD were likely introduced due to thickness changes in the walls 
of the MCA while under the influence of the two different pressure loads. 
Compliant magnesium stent designs that facilitate high cyclic strain 
amplitude levels that are closer to the normal physiological range (5-8%) (Draney et 
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al., 2002), and thus maintain the anti-proliferative effect of cyclic strain amplitude on 
SMCs (Colombo et al. 2012), could offer an effective strategy to reduce ISR rates. 
The subsequent corrosion-induced loss of mechanical integrity of magnesium stents 
(Figure 4.19(f)) should produce a further temporal increase in the cyclic strain 
amplitude. Upon completion of stent absorption, reconstitution of normal vessel 
vasomotor function can be expected; thus removing many of the known stimuli for 
IH and ST (Jabara et al., 2009). It has been suggested that current BAS may not be 
ideal for patients with severe amounts of lesion calcification due to their limited 
deliverability scaffolding properties (Kern, 2012). Conceptually, an ideal candidate 
group for magnesium stents and other types of BAS may be young patients with 
small plaque burden and focal disease or those requiring treatment of vulnerable 
plaques prior to plaque rupture (Sabate, 2014). 
5.3 Corrosion Experiments 
The micro-galvanic corrosion attack observed in this work (Figure 4.13(c)) and, the 
tendency toward a uniform localised corrosion that progressed in a layer by layer 
manner (Figure 4.13(f)), is in agreement with results reported for larger samples of 
WE43 in similar SBF compositions in the literature (Kalb et al., 2012). However, the 
steady-state corrosion rates (0.021-0.027 mg cm-2 h-1) observed in this work (Figure 
4.18(b)) were between eight and twenty orders of magnitude lower than those 
reported for larger WE43 specimens (Rettig and Virtanen, 2009; Zhang et al., 2012) 
and may be partly attributed to the increased resistance to galvanic corrosion 
afforded by materials processing of the precursor tubes (Ge et al., 2013; Wang et 
al., 2007). Further, the surface treatments imparted a magnesium phosphate 
surface layer with reduced impurity levels (Nwaogu et al., 2009) and low surface 
roughness (Gray-Munro et al., 2009; Walter et al., 2013) which significantly 
improved corrosion resistance. This layer may have contributed to the low corrosion 
rate observed for specimens with 0% plastic strain (Figure 4.12) though some 
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degradation of the layer was observed after 1 d immersion (Figure 4.13(a)). The 
layer was significantly more degraded on specimens with plastic strain after 1 d 
(Figure 4.14(a)). 
Mass loss measurements, which are applicable to materials exhibiting near-
uniform corrosion, revealed two different trends among the specimens (Figure 4.12). 
Specimens with 0% plastic strain exhibited a low initial corrosion rate and a largely 
linear rate thereafter; while higher levels of plastic resulted in larger increases in 
mass loss in the first 2 d of immersion and moderate increases in steady-state 
corrosion rate thereafter. The increased mass loss due to plastic strain may be 
attributed to the likely damage caused to the brittle surface oxide and a deformation-
induced acceleration in micro-galvanic attack combined with hydrogen embrittlement 
and stress corrosion cracking (SCC). Damage and dissolution of the surface oxide 
and severe pitting attack accompanied by cracking of the corrosion layer (Figure 
4.14(a-b)) led to greater levels of material removal from the surface (Figure 4.14(c)) 
and increased corrosion on laser cut edges (Figure 4.14(e)). These findings are in 
agreement with those from previous mechanical-electrochemical studies which 
showed that plastic strain (5.5%) induced significant increases in both the pitting 
susceptibility of grains (one order of magnitude) and the cathodic reactions at grain 
boundaries (two order of magnitude) of an aluminium alloy in NaCl solution (Krawiec 
et al., 2012). Similar findings have been reported for magnesium alloys that were 
subjected to compression loading (Snir et al., 2012). 
The corrosion-induced reduction in the thickness of stent struts (Figure 
4.18(c)) was greatest in plastic hinge regions (Figure 4.18(d)) and contributed to a 
46% reduction in radial stiffness after 60 h (Figure 4.19(f)) despite a total mass loss 
of only 28% for the stent. The layer of corrosion products that are formed on the 
specimen surfaces appeared to offer little protection to the substrate and thus 
corrosion rates remained largely linear (Figure 4.18(b)). The composition of the 
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corrosion products, as determined by EDX analysis, was rich in Ca, O, P, Mg, Cl 
and C, and was similar to that reported for WE43 specimens in similar solutions 
(Kalb et al., 2012; Rettig and Virtanen, 2009). The shape of the mass loss curve and 
the loss of approximately 25-30% stent mass after 60 h, due to uniform micro-
galvanic and SCC corrosion processes, is in agreement with results reported for an 
electropolished AZ31 stent (Wu et al., 2012). 
The corrosion-induced reduction in the stress-strain response and 
mechanical properties (UTS, εu, E and σy) observed in experiment A (Figure 4.15), 
likely resulted from the reduction in dogbone specimen cross-section and the 
influence of stress concentrations in pitted regions and, was similar to the reduced 
stress-strain responses reported for loaded and non-loaded magnesium specimens 
(Bowen et al., 2012; Winzer et al., 2008). Compared to specimens with 0% plastic 
strain, specimens with plastic strain exhibited a further reduction in mechanical 
properties, most notably for εu, E and σy. It was concluded that the presence of 
plastic strain increased the micro-galvanic corrosion activity and induced 
intergranular and transgranular SCC (Figure 4.17). Similar SCC failure modes have 
been reported for RE magnesium alloys after slow strain rate tests in NaCl solution 
(Kannan et al., 2008). Magnesium alloys are susceptible to a number of stress-
mediated SCC processes which may lead to the rupture of the surface film, H2 gas 
ingress and embrittlement and crack initiation and crack growth leading to fracture 
(Winzer et al., 2005a). 
The corrosion-induced reduction in mechanical strength observed for 
specimens with 0% plastic strain (Figure 4.15(d)) was less rapid than that reported 
previously for AZ31 and Mg–6Zn alloy specimens in similar studies (Grogan et al., 
2011; Zhang et al., 2010) and, may be attributed to the relatively uniform reduction 
in specimen cross-section seen in this work. Consequently, a mass loss of 40% for 
dogbone specimens and 28% for stents, corresponded to a 50% reduction in 
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specimen mechanical strength, compared to a mass loss of only 10-20% in similar 
studies (Grogan et al., 2011; Zhang et al., 2010). By comparison, the pitting attack 
observed in this work (Figure 4.13(c)) was less localised, owing in part to the 
relatively low pitting factor (defined as the ratio of the deepest penetration to the 
average penetration) of WE43 compared to other magnesium alloys (Kalb et al., 
2012). 
While no significant differences were observed in the corrosion behaviour on 
the inner and outer walls of specimens, the corrosion attack observed on laser cut 
edges had a different morphology (Figure 4.13(g)) and progressed at a higher rate 
when compared to the other surfaces, particularly in specimens with plastic strain 
(Figure 4.14(d-e)). Since laser cutting may influence surface roughness, alloy 
microstructure and expose higher index crystal planes of lower corrosion resistance 
(Liu et al., 2008), in the absence of subsequent surface modification or coating, 
higher corrosion rates can be expected on laser-cut edges; though a detailed study 
has not been carried out for magnesium stents in this regard. 
The results of experiment A and B suggest that corrosion behaviour was 
strongly influenced by alloy microstructure and the magnitude of deployment strains 
in this study. The findings demonstrate the potential for improvements in the 
mechanical and corrosion behaviour of magnesium stents through improvements in 
material processing and surface treatments and, optimisation of stent designs in 
order to minimise deployment strains. Based on these findings, it is likely that 
uniform deployed configurations and high strut apposition rates are critical to ensure 
uniform and controlled corrosion of magnesium stent struts in vivo, with an 
accompanying controlled reduction in corrosion-induced mechanical integrity, owing 
to the influence of complex blood-tissue interactions on the corrosion behaviour of 
magnesium alloys (Pierson et al., 2011; Wittchow et al., 2013). 
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The macroscopic tensile stress-strain response of non-corroded dogbone 
specimens (Figure 4.15) was shown to be different to that reported for bulk 
specimens of WE43 (Gu et al., 2010). Compared to bulk specimens with larger grain 
sizes, dogbone specimens exhibited decreases in σy, modest decreases in UTS but 
no significant differences in εu and εf. These findings are largely in agreement with 
those from experimental (Guo et al., 2011) and numerical (Grogan et al., 2014b) 
studies that examined the influence of grain size on the mechanical properties of 
non-corroded magnesium materials. The differences in the mechanical properties of 
dogbone and bulk specimens may be attributed to influences such as, the fine-
grained microstructure of the precursor tube (Ge et al., 2013) and size effects 
resulting from the small specimen geometry and its processing. Magnesium 
specimens with small grain size have a larger grain boundary fraction and 
consequently release local strain energy faster, thereby exhibiting lower E values 
(Moitra, 2013). 
Studies of the corrosion behaviour of pure magnesium wires in static SBF 
and rat artery models suggest that in vitro corrosion rates (as denoted by a 
combined metric) are approximately three times greater than those observed in vivo 
(Bowen et al., 2013). The lower in vivo corrosion rates observed for magnesium 
alloys have been attributed to influences such as the adsorption of proteins on the 
implant surface, the availability of oxygen (Feyerabend et al., 2012), the levels of 
blood flow in nearby tissues (Willbold et al., 2013), the suppression of microgalvanic 
corrosion due to encapsulation (Zainal Abidin et al., 2013) and the influence of 
macrophages which can release acid digesting substances (Wittchow et al., 2013). 
The in vitro corrosion rate observed in this study for the WE43 stent was lower than 
those previously reported for WE43 specimen in similar SBF solutions. However, the 
likely in vivo lifetime of the stent would be far too short to scaffold a coronary artery 
for the six-to-nine month period required, as was the clinical experience with the 
 105 
 
(WE43) bare-metal Biotronik AMS-1 (Erbel et al., 2007). Future improvements in 
magnesium metallurgy and materials processing, combined with more effective 
surface treatments and stent coating strategies should permit better control of 
degradation rates and allow the lifetime of magnesium stents to be prolonged. Given 
the high susceptibility of magnesium alloys to galvanic corrosion, accelerated in vitro 
corrosion testing via electrochemical testing techniques, such as open circuit 
potential and cyclic potentiodynamic polarisation testing (Gerber, 2008; Nascimento 
and Zeddies, 2007), should provide useful methods for rapid evaluation of the 
corrosion behaviour of different magnesium alloys for biomedical applications. 
Biodegradable polymers such as poly (l-lactic acid) (PLLA), poly (L-
caprolactone) (PCL) and poly (glycolic acid) (PGA) have been approved for 
numerous clinical applications (O’Brien and Carroll, 2009). More recently, the use of 
these polymers as protective coatings intended to increase the corrosion resistance 
of biodegradable magnesium has been explored. PCL and PLLA display good 
adhesion and cytocompatibility properties, and offer significant reductions in the 
corrosion rate of the magnesium substrate (Xu and Yamamoto, 2012). In a rat 
model, poly(1,3-trimethylene carbonate) (PTMC) coatings reduced the corrosion 
rate by three orders and one order of magnitude compared to bare and PCL coated 
Mg-Zn-Mn alloy specimens, respectively (Wang et al., 2013). A PLGA coating was 
used on the Biotronik AMS-3 stent. In animal trials, a mixture of 85% lactide and 
15%  glycolide provided the lowest intimal area at 28 days and 180 days, and the 
highest endothelialisation score at 28 days (Wittchow et al., 2013). Chen et al. 
(Chen et al., 2011) noted a special interaction between high purity magnesium and 
both PCL and PLA coatings under dynamic SBF flow conditions, which had a 
deleterious effect on corrosion performance. Such interactions between polymer 
coating and the magnesium substrate could pose challenges to the future 
development of drug-eluting magnesium stents. 
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5.4 Corrosion Modelling 
The peak strain (~27%) predicted by the FE model for the deployed stent was 
significantly greater than the experimentally observed value of failure strain for 
WE43 (~20%). Strain in the FE model was predicted in the circumferential direction 
(first principal strain) which was the direction most relevant to the stent deployment 
analysis. It should be noted that the strain state in the deployed stent was more 
complex than that induced experimentally by simple uniaxial tensile loading of the 
dogbone specimens. Therefore, it is suggested that the use of a ductile failure 
criterion, such as Oyane’s Criterion, within the FE model would facilitate better 
prediction of material failure in future stent deployment analyses. 
Observations from the corrosion experiments showed that uniform micro-
galvanic corrosion and SCC were likely to be the dominant corrosion processes for 
both dogbone and stent specimens. The results also suggested a plastic strain 
mediated corrosion attack for both specimens, as has been observed in previous 
studies of magnesium alloys (Snir et al., 2012; Wittke et al., 2014). Therefore, an 
element-specific plastic strain parameter (φe) was introduced in this work in order to 
account for the effects of plastic strain induced corrosion in the modelling 
framework. The plastic strain corrosion model, which was calibrated based on the 
results of the corrosion experiments, was capable of predicting the experimentally 
observed mass loss and the corrosion-induced reduction in stress-strain response of 
the dogbone and stent specimens, whereas the uniform corrosion model failed to 
capture the observed effects. The use of a non-linear relationship between εp1 and φe 
for elements with εp1 values above of 8.4%, rather than a simple linear relationship, 
in the corrosion model better captured the strain-mediated corrosion attack at plastic 
hinge regions (Figure 4.25). Although only the proportion of elements in the model 
having εp1 values was modest (4%), the increased corrosion rates prescribed for 
these elements in the plastic strain model led to significantly greater reductions in 
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the predicted radial stiffness for the stent, without significantly increasing the overall 
mass loss of the stent, when compared to the linear corrosion model. This approach 
(i.e. the use of a non-linear relationship between εp1 and φe) was in contrast to 
previous studies where a ductile failure condition was employed by setting D = 1 for 
elements in which strains exceeded those observed experimentally at the UTS 
(Gastaldi et al., 2011; Grogan et al., 2011). Thus, in these models, elements may be 
immediately removed from the mesh at the start of the corrosion simulation leading 
to the prediction of instantaneous mass loss at a simulation time of zero. 
The plastic strain parameter (φe) used in this work accounted for both the 
effects of corrosion and plastic strain (strain hardening) in a single parameter. It may 
be possible to develop other parameters for use in the corrosion model which 
delineate the individual influences of plastic strain and corrosion on specimen 
mechanical integrity and mass loss. Figure 5.1(a) shows the typical stress-strain 
response for a specimen induced with 2.7% plastic strain (curve 1) and, the 
subsequent response for the same specimen prior to corrosion (curve 2) and after 
corrosion (curve 3). The difference between the response observed at curve 1 and 2 
indicated the loss of mechanical integrity (reduced ductility) due to plastic strain 
while that observed at curve 2 and 3 indicated the loss of mechanical integrity due to 
corrosion alone. As shown in Figure 5.1(b), the mass loss due to plastic strain 
(green curve) could be delineated by subtracting the mass loss curves for 0% and 
2.7% plastic strain. 
This use of the element exposure parameter (κe) which scaled the corrosion 
rate of the element according to the number of exposed element faces, allowed the 
model to predict the rounding of initially sharp strut corners which is expected for a 
diffusion-controlled corrosion process (Figure 4.25). This feature could also be 
modified to include the effects of other corrosion phenomena that may be influenced 
by the number of exposed element faces, such as the growth of corrosion pits. 
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Although the effects of pitting corrosion were not included in his work, the results of 
the experiments suggested that the pitting tendency of the WE43 was low when 
compared to that in previous studies where it was the primary corrosion process 
(Grogan et al., 2011). The model developed in this work is deterministic in nature. 
Probabilistic models are useful as they can be used to handle variability and 
uncertainty which are inherent in many corrosion processes (MacDonald, 1994). 
 
Figure 5.1 (a) Typical stress-strain response for a specimen induced with 2.7% 
plastic strain (curve 1) and, the subsequent response (inset) for the same specimen 
prior to corrosion (curve 2) and after corrosion (curve 3), (b) Mass loss curve (green) 
that is driven by plastic strain alone 
 Simulation of stent performance may result in large and computationally-
expensive FE models owing to strong material and geometrical nonlinearities and, 
complex multiple contact phenomena. The RUC corrosion model developed in this 
work had good computational efficiency, requiring approximately nine CPU hours on 
a single quad-core Intel i7 (2.6 GHz) on a desktop computer. The RUC stent model 
offered significant reductions in model size and solution time which is especially 
useful in the preliminary stages of stent design where many cycles of iteration 
between the simulation and parameter selection are necessary (Xia et al., 2007). 
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5.5 Summary and Limitations 
A number of limitations of this study should be highlighted. No post-cut annealing 
was used to relieve residual stresses (Poncin and Proft, 2003) in the specimens 
following laser cutting. However, the precursor tubes were pre-annealed prior to 
laser cutting. The heat generated during laser cutting was minimised by using a 
pulsed laser source, high pressure shield gas, and cutting paths and laser 
parameters intended to minimise heat effects in the machined parts.  
Although the surface treatments employed in this work are likely to differ 
from those used for the Biotronik AMS-1 (Erbel et al., 2007), they provided effective 
and inexpensive methods for functionalising the laser cut stents. The suitability of 
the processing route used was demonstrated in bench tests where all stents were 
expanded successfully to a SER of 2.1 and exhibited a uniform deployed geometry 
with no evidence of strut fracture. 
While the thickness of the dogbone specimen was equal to that of the stent 
strut (140 µm), its width (1.85 mm) was approximately 1.5 orders of magnitude 
greater. Therefore, the mechanical and corrosion behaviour observed for the 
dogbone specimens was indicative of behaviour at that size-scale. However, when 
compared to the existing studies for magnesium stents in the literature, the 
specimen size, materials processing and surface treatments used in this work 
represent a significant step towards elucidating the precise behaviour of magnesium 
stent struts. Furthermore, the use of finished WE43 stents in the experiments of this 
work to elucidate device performance characteristics represents a significant 
contribution to knowledge.  
The experimental performance of the stents was determined in MCAs that 
mimicked only the passive mechanical properties of healthy coronary arteries under 
static pressure conditions, though the results provided useful data regarding the 
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comparative performance of WE43 and 316L stents. The in vitro conditions used in 
the corrosion experiments yielded useful fundamental information regarding the 
corrosion behaviour of the stent and the alloy material but they cannot fully account 
for the complex tissue interactions that may influence the performance of 
magnesium devices in vivo (Pierson et al., 2011). However, it is noted that the 
corrosion experiments in this work were carried out under sterile conditions in a cell 
culture incubator; only a few such studies have been reported for magnesium 
(Kirkland et al., 2010).  
The influence of stent crimping, compressive loading and dynamic (fatigue) 
loading on corrosion behaviour was not examined in this work. The corrosion model 
was calibrated in experiments that examined corrosion behaviour at three plastic 
strain values (0%, 2.7%, 8.4%) and at intervals of twenty four hours. The first 
principal plastic strain (εp1) which acted parallel to the applied uniaxial tensile loading 
in the dogbone specimen, was employed as the mediator of the corrosion in the 
corrosion models. It is noted that the plastic strain state in the stent was non-uniaxial 
owing to the complex loading pattern that is associated with the stent deployment 
process though the model was still capable of capturing the experimentally observed 
behaviour. Linear rather than continuous functions were used in the representation 







6.1 Main Findings 
The main aim of this study was the determination of the mechanical and corrosion 
performance of an absorbable magnesium stent using experimental and numerical 
analysis. A processing route was identified by which viable balloon-expandable 
coronary stents were manufactured from precursor tubes of the WE43 alloy using a 
combination of laser cutting and chemical and plasma-based surface treatments. 
The physical and chemical characteristics of the stent surfaces produced were 
revealed through SEM, AFM and EDX analyses. To the author’s knowledge, this is 
the first study to fully describe the fabrication of WE43 stents and to describe the 
surface treatment of magnesium stents by plasma processing (RIE). 
While limited data regarding the performance of the Biotronik AMS-1 stent 
(also WE43) has been reported in clinical trials (Erbel et al., 2007), this is the first 
experimental study to report on the mechanical and corrosion performance of a 
WE43 stent. It is also the first study to demonstrate the critical role of deployment-
induced plastic strain on the subsequent corrosion behaviour and temporal 
scaffolding ability of a magnesium stent. By way of novel corrosion experiments, 
plastic strain was shown to significantly increase corrosion rates, particularly at 
plastic hinge regions, thus leading to a deformation-induced acceleration of the 
underlying corrosion processes. The likely primary corrosion process was identified 
as uniform micro-galvanic corrosion in non-deformed specimens and as uniform 
micro-galvanic corrosion combined with SCC and hydrogen embrittlement for 
specimens with plastic strain. Damage to the brittle surface oxide caused by plastic 
strain was also thought to play a significant role in accelerating the corrosion attack. 
Relatively modest mass losses at hinge regions were shown to induce significant 
reductions in the temporal radial stiffness of the stent. 
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The corrosion rates observed in this work were found to be significantly 
lower, with a reduced tendency toward corrosion processes such as pitting 
corrosion, when compared to many of the existing corrosion studies of magnesium 
alloys. The rate of mass loss and the nature of the underlying corrosion processes 
observed for the stent was comparable with those of an electropolished AZ31 stent 
in a previous study (Wu et al., 2012). When compared to the mechanical properties 
reported for bulk WE43 specimens in the literature, the non-corroded dogbone 
specimens used in this work exhibited significantly lower mechanical properties, 
particularly with respect to E, σy and UTS. The observed effects were strongly linked 
to the material microstructure and the surface properties of the specimens and thus 
these findings highlight the vital importance of conducting testing on the stent itself 
or a sample of the stent in its final form and finish. The experimental data presented 
in this work, regarding the mechanical and corrosion performance of WE43 stents 
and specimens, will serve as input in future computational models of stent 
deployment, corrosion analysis and stent optimisation studies. 
In the deployment experiments, the WE43 stent deployed at a significantly 
lower range of balloon pressures than the commercially-available 316L stent. This 
could potentially be beneficial in terms of reducing arterial injury and hence ISR in 
arteries with low to moderate levels of disease where predilation of stenosis may be 
avoided. However, this requires further investigation. The WE43 stent was found to 
have a lower initial radial stiffness that was observed to decrease with immersion 
time in the corrosion experiments. Non-corroded WE43 stents were shown to 
support higher levels of cyclic strain amplitude which plays a crucial role in reducing 
ISR, owing to the anti-proliferative influence of higher cyclic strain amplitude on 
SMCs (Colombo et al., 2009). These findings highlight the need for improved 
understanding of the biomechanical environment in stented vessels. In the future, 
modulation of the cyclic strain amplitude in vessels stented with compliant 
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magnesium stent designs that have steerable corrosion kinetics should provide a 
method to improve the ISR outcomes observed with current stents. 
The need for corrosion models that explore the interaction of plastic strain 
and plastic damage with corrosion damage has been recognised as one of the 
current challenges in degradable material modelling (Gastaldi et al., 2011). A FE 
based plastic strain mediated phenomenological corrosion model was developed in 
this work and was calibrated based on the results of the corrosion experiments. It 
was found to be capable of predicting the experimentally observed plastic strain 
mediated mass loss profile and the corrosion-induced reduction in the radial 
stiffness of the stent over time. To the author’s knowledge, the results presented 
here represent the first experimental calibration of a plastic strain mediated 
corrosion model of a corroding magnesium stent.   
The results of this study provide new insights into the performance of an 
absorbable magnesium stent and the fundamental corrosion processes that lead to 
the temporal degradation of the stent. The findings will help direct future design 
efforts towards the minimisation of plastic strain during device manufacture, 
deployment and in-service, in order to reduce corrosion rates and prolong the 
mechanical integrity of magnesium devices. Improvements in the corrosion 
performance and biocompatibility of magnesium stents are needed and may be 
achieved through improved stent design, advances in metallurgy and materials 
processing, better surface treatments and coating strategies (Kitabata et al., 2014).  
FE modelling is a powerful tool for device evaluation and corrosion 
simulations and is a requirement for FDA approval of many medical devices, such 
as coronary stents. Although the model developed in this work was validated and 
applied to the case of a WE43 stent, it can be readily adapted in order to study the 
behaviour of other alloys and devices. The model can also be used to examine the 
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effects of different materials processing, alloy compositions, and surface treatments 
on overall device performance. It provides a flexible modelling framework which can 
be adapted to explore other potentially relevant corrosion processes, such as pitting 
and crevice corrosion, through modification of the damage law (Eqn. 3.4). 
6.2 Future Work 
The influence of the surface treatments used in this study on the various surface 
properties which effect the biocompatibility of magnesium (Yang et al., 2011) require 
further investigation. Although a bare-metal magnesium stent platform, similar to the 
that developed in this work, demonstrated good biocompatibility in clinical trials 
(Erbel et al., 2007), the toxicology and metabolic pathway of the RE elements used 
in the WE43 alloy require further investigation (Gu and Zheng, 2010). 
Biocompatibility testing should include cytotoxicity, haemolysis and platelet adhesion 
testing, cell viability assays and additional corrosion analysis performed on 
specimens with materials processing and surface treatments that are relevant to 
stents. The work presented in this study should be advanced by carrying out 
experimental mechanical testing of strut-sized magnesium specimens, as has been 
investigated previously for traditional stent materials such as 316L (Murphy et al., 
2003). However, the determination of specimen mass loss by gravimetric 
measurement at these size-scales represents a significant challenge. Hence, 
alternative approaches to determine specimen corrosion rates may be required such 
as Inductively Coupled Plasma Mass Spectrometry (ICP-MS) which can be used to 
measure the concentration of magnesium ions released into solution by corroding 
magnesium specimens (Schinhammer et al., 2010). 
Drug-elution studies have shown that long-lasting antiproliferative effects do 
not require sustained drug release (Garg & Serruys, 2010). These findings suggest 
that effective magnesium BAS could be composed of an absorbable metal 
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backbone coated with an antiproliferative drug, rather than requiring drug wells or 
the inclusion of antiproliferative agents in the backbone material (Topol, 2008). The 
widespread adoption of magnesium stents requires improvements in device efficacy 
which could be achieved through the development of a biocompatible coating 
technology that permits control of drug delivery and device corrosion rate. 
Since the study of plastic damage was the original application of the CDM 
approach, future CDM-based models of corrosion damage could contribute to 
exploring the interaction of plastic strain with corrosion damage for a range of 
absorbable magnesium devices. The various components of plastic strain that are 
induced during the processing of precursor tubes and stent manufacturing, as well 
as those that result from fatigue loading in vivo, could be used in future CDM models 
as the impetus for corrosion within the model. One approach might be to use 
deformation-induced changes in electrochemical measurements in the magnesium 
alloy as mediators of corrosion behaviour in the model. A number of studies have 
explored this relationship between deformation-induced electrochemical changes 
and corrosion behaviour in magnesium alloys (Snir et al., 2012; Wittke et al., 2014). 
In the future, advanced imaging modalities and lower-cost screening tests 
may enable identification and pre-emptive treatment with BAS of patients with 
vulnerable plaques in order to reduce morbidity and mortality (Kukreja et al., 2009). 
The unique properties of magnesium  devices will lead to new treatment options and 
improved outcomes for patients and should play a role in revolutionising medical 
devices (Farraro et al., 2013). Tissue engineering strategies may be combined with 
magnesium, such as the addition of biological agents to expedite healing of hard 
and soft tissues. Such devices could find utility in a host of implants such as 
coronary and ureteral stents (Lock et al., 2012), fracture fixation devices, ligament 
and tendon reconstruction implants (Walton and Cotton, 2007), sutures and 
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A.1 Compositional analysis 
Three specimens (n=3) of the WE43 precursor tube were acid digested using a 
Milestone Microwave Digestion System and analysed using Inductively Coupled 
Plasma Mass Spectrometry (ICP-MS) (7500 ICP-MS, Agilent Technologies) in order 
to determine the compositional content of magnesium and the three main alloying 
elements (Y, Zr & Nd). The weight % of magnesium and the alloying elements was 
found to be consistent with that specified by the manufacturer of WE43 (Magnesium 
Elektron, 2007), as shown in Table A.1. 
 
Table A.1 Elemental composition (average weight %) of WE43 tube specimen 
determined by ICP-MS 
A.2 Additional Data from Corrosion Experiment A 
 
Figure A.1 Stress-strain curves (terminating at the UTS) for dogbone specimens 
based on the results of experiment A, (a) 0% PS (b) 2.7% PS and (c) 8.4% PS. 
Error bars represent 95% confidence intervals derived from T-table. 
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A.3 APDL Implementation of Corrosion Model 
!===================================================================== 
!----- Plastic strain-mediated corrosion algorithm V5.1 ----------- 
!----- Written by: Emmet Galvin, Date: 10/07/14 -------------------- 
!----- All text to the right of “!” are comments ------------------------ 
!===================================================================== 
 
!--------------- Set control parameters for corrosion algorithm ----------------------- 
finish 
/prep7     ! Enter preprocessor 
k_U=8.1667e-3    ! Corrosion kinetic parameter (hr^-1) 
Delta_t=1    ! Time step (hr) 
tMax=60    ! Maximum solution time (hr) 
ItNum=tMax/Delta_t+1   ! Set number of iterations  
ItNum=nint(ItNum)   ! Find nearest integer value of ItNum 
INL=ItNum+1 




*get,J,elem,,count   ! Get the number of elements (J) in  
esel,all     ! the selected set 
 
!--------------- Create element characteristic length (L_e) array -------------------- 
*del,L_e 
*dim,L_e,array,J   ! Create array for L_e 
*do,EE,1,J 
 *get,V_e,elem,EE,volu  ! Get element volume 
 L_e(EE)=(V_e)**(1/3)  ! Get L_e and write  
*enddo     ! to L_e array 
 
!--------------- Create damage (D) array ------------------------------------------------- 
*del,De1 
*dim,De1,array,J,INL   ! Create array for De1 
*do,EE,1,J 




!--------------- Create results array ------------------------------------------------------- 
*del,MML 
*dim,MML,array,INL,4   ! Create results array 
MML(1,1)=0    ! Iteration number 
MML(1,2)=0    ! Solution time (hr) 
MML(1,3)=J    ! Number of live elements 
MML(1,4)=0    ! Model mass loss(%) from DES 
 
!--------------- Create K array --------------------------------------------------------------- 
*del,K 
*dim,K,array,J,9    ! K (no. of exposed element faces) array 
 
*do,EE,1,J 
 *do,xx,1,9    










*do,xx,1,J3    
 ff=elnext(i) 
 K(ff,7)=1   ! Set K(ff,7)=1 for elements 




!--------------- Create current element strain (CES) array ----------------------------- 
*del,CES 
*dim,CES,array,J 
*do,EE,1,J    
 CES(EE)=0   ! CES array records element first  
*enddo     ! principal plastic strain 
 
!--------------- Create DES (current Element Damage) array ------------------------ 
*del,DES 
*dim,DES,array,J   ! DES array records element damage (D) 




!--------------- Create recent death (RDM) array ----------------------------------------- 
*del,RDM 








!--------------- Create material model number (MMN) array ------------------------- 
*del,MMN 
*dim,MMN,array,J 
*do,EE,1,J    
 MMN(EE)=1   ! Set initial material model  
*enddo     ! for all elements to 1 
alls 
 
!--------------- Create plastic strain parameter (Phi) array --------------------------- 
!--------------- to scale DeDt based on current element strain (CES) ------------- 
*DIM,mult1,TABLE,6,6,1, , ,    
*TAXIS,mult1(1,1,,),,  0,0.027,0.084,0.12,0.168,0.35  ! Plastic strain  
*TAXIS,mult1(1,1,,),2,24,48,96,144,192,240  ! Time (hr) 
mult1(1,1)=0.368, 2.190, 5.830, 25.00, 70.00, 700.0 
mult1(1,2)=1.287, 1.265, 1.264, 6.000, 12.00, 20.00 
mult1(1,3)=1.000, 0.632, 0.630, 1.500, 2.000, 3.000 
mult1(1,4)=1.035, 1.092, 1.149, 1.150, 1.250, 1.350 
mult1(1,5)=0.862, 1.149, 1.093, 1.093, 1.093, 1.093 
mult1(1,6)=0.785, 1.095, 1.483, 1.800, 2.000, 2.200 
 
!--------------- Simulate Stent Deployment & Recoil ----------------------------------- 
finish     ! Finish preprocessor 
/solu     ! Enter solution 
nlgeom,on    ! Activate large deformation controls 
















!--------------- Update CES array ---------------------------------------------------------- 
finish     ! Finish solution 
/post1     ! Enter postprocessor 
etable,epl,eppl,1   ! create etable 'epl' of first 
*do,EE,1,J    ! principal plastic strain 
 *get,pps,elem,EE,etab,epl 









antype,,restart,,,continue  ! CES data is lost after restart so  
parres, new, params1,,   ! must read from text file 
parres, change, scalparams,,  
nsubst,1,1,1 




!--------------- Corrosion Algorithm Iterative cycle ----------------------------------- 
*do,I,2,ItNum    ! I varies from 2 to ItNum 
 
 CT=I-1    ! Corrosion Time (hr) 
 /gopr     ! Reactivate suppressed printout 
 
 ST=Delta_t*(CT)   ! Solution Time (hr) 
 *if,ST,ge,0,and,ST,le,24,then  ! y mediates mult1 array column  













 !--------------- Update Ke array ------------------------------------------------ 
 esel,s,live   ! Select live elements 




 *do,EE,1,J   ! Find number of neighbouring elements 
  *do,fn,1,6 
   *if,eladj(EE,fn),lt,1,then 
    K(EE,fn)=0 
   *else 
    *get,ELS1,elem,eladj(EE,fn),attr,live 
        *if,eladj(EE,fn),ge,1,and,ELS1,eq,1,then 
      K(EE,fn)=1 
     *else 
      K(EE,fn)=0 
     *endif  
   *endif 
  *enddo 
 
K(EE,8)=6-(K(EE,1)+K(EE,2)+K(EE,3)+K(EE,4)+K(EE,5)+K(EE,6)+K(EE,7)) 
     ! K(EE,8)= number of exposed elem faces  
  *if,K(EE,8),eq,0,then  ! Set Ke parameter based on K(EE,8) 
   K(EE,9)=0.000   
  *elseif,K(EE,8),eq,1,then     
   K(EE,9)=1.000 
  *elseif,K(EE,8),eq,2,then     
   K(EE,9)=1.289 
  *elseif,K(EE,8),eq,3,then     
   K(EE,9)=2.182 
  *elseif,K(EE,8),eq,4,then     
   K(EE,9)=2.667 
  *elseif,K(EE,8),eq,5,then     
   K(EE,9)=2.805 
  *elseif,K(EE,8),eq,6,then     
   K(EE,9)=2.949   
  *endif 
 *enddo 
 
 !--------------- Corrosion process--------------------------------------------- 
 esel,s,live 
 esel,r,type,,1    
 nsle,r  
 nsel,r,ext 
 nsel,u,,,allbcnode 
 esln,r     ! Select external elems for corrosion 
 
 *do,EE,1,J 
  *get,ESS,elem,EE,esel  ! Get elem selection status (ESS) 
 
  *if,ESS,eq,1,then 
   *get,ELS,elem,EE,attr,live ! Element life status 
  *endif 
 
 
  *if,ESS,eq,1,and,ELS,eq,1,then 
   Phi=mult1(CES(EE),y)  ! Set Phi from mult1 array 
   De1(EE,I)=De1(EE,I-1)+((DeDt*Phi*K(EE,9))/L_e(EE)) 
  *else 
   De1(EE,I)=De1(EE,I-1) 
  *endif 
 
  !------- Change material model number or kill element ------ 
  *if,De1(EE,I),ge,0,and,De1(EE,I),le,0.1,then   
    /wait,0 
   *elseif,De1(EE,I),ge,0.1,and,De1(EE,I),lt,0.2,then 
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    MPCHG,2,EE 
   *elseif,De1(EE,I),ge,0.2,and,De1(EE,I),lt,0.3,then 
    MPCHG,3,EE 
   *elseif,De1(EE,I),ge,0.3,and,De1(EE,I),lt,0.4,then 
    MPCHG,4,EE 
   *elseif,De1(EE,I),ge,0.4,and,De1(EE,I),lt,0.5,then 
    MPCHG,5,EE 
   *elseif,De1(EE,I),ge,0.5,and,De1(EE,I),lt,0.6,then 
    MPCHG,6,EE 
   *elseif,De1(EE,I),ge,0.6,and,De1(EE,I),lt,0.7,then 
    MPCHG,7,EE 
   *elseif,De1(EE,I),ge,0.7,and,De1(EE,I),lt,0.8,then 
    MPCHG,8,EE 
   *elseif,De1(EE,I),ge,0.8,and,De1(EE,I),lt,0.9,then 
    MPCHG,9,EE 
   *elseif,De1(EE,I),ge,0.9,and,De1(EE,I),lt,0.999,then 
    MPCHG,10,EE 
   *elseif,De1(EE,I),ge,0.999,then     
    De1(EE,I)=1 
    ekill,EE  ! If D>1 then kill element 
    RDM(EE,I)=1 ! Record element death in RDM array 
  *endif 
 
  DES(EE)=De1(EE,I)  ! Update DES array for mass loss
 *enddo     ! calculation 
 
 !--------------- Update Results Array ---------------------------------------------------- 
 esel,s,live 
 esel,r,type,,1 
 *get,NoE,elem,0,count   ! Get the number of live elements 
 *vscfun,DESSUM,sum,DES(1) ! Sum Damage (D) for all elements 
 
 MML(I,1)=CT    ! Iteration 
 MML(I,2)=Delta_t*(CT)   ! Solution time (hr) 
 MML(I,3)=NoE    ! Number of live elements 
 MML(I,4)=100*(DESSUM/J)  ! % Mass loss based on D 
  
 solve     ! *** SOLVE *** 
 save 
 
 finish     ! Finish solution 
 /post1     ! Enter postprocessor 
 set,last   
 rsys,1     ! Cylindrical results co-ord system 
 
 !--------------- Update CES array ------------------------------------------------- 
 esel,s,type,,1 
 etable,eps,eppl,1   ! Set up etable 'eps' for  
 *do,EE,1,J    ! 1st principal plastic strain 
  *get,pps,elem,EE,etab,eps ! Write plastic strains to CES 
 CES(EE)=pps    ! array 
 *enddo 
 
 !--------------- Update MMN array ------------------------------------------------ 
 *do,EE,1,J 
 *get, EMMN, elem, EE, attr, mat 
  MMN(EE)=EMMN 
 *enddo 
 





 *get,uxmax%I%,sort, ,max 
 alls 
 
 !--------------- Corrosion plot------------------------------------------------------ 
 esel,s,type,,1 
 /cont,1,20,0,0.1,1   ! Set values for contour plot 
 etable,CVPH,s,x   ! Set sx as corrosion value  
 *vput,De1(1,I),elem,1,etab,CVPH ! placeholder 
 esel,s,live     ! Select live elements 
 esel,r,type,,1 
 /efacet,1  
 /title,Corrosion %MML(I,2)%[hr] (Delta_t=%Delta_t%[hr]) 
 pletab,CVPH    ! Plot element table 
 /view,1,1,1,1    
 /ang,1     
 /auto,1  
 /rep,fast 
 /input,0plots,txt     
 alls 
 




 antype,,restart,,,continue  ! Restart analysis 
 parres, new, scalparams,,  ! Read scalar parameters  
 parres, new, params%I%, , 
 
 *do,EE,1,J 
  *if,RDM(EE,I),eq,1,then  ! Remove killed elements 
   ekill,EE 












**Solution completed**    ! Send message to GUI 
finish 
/out      ! Alert user by email 
/mail, --,emmet.galvin3@mail.dcu.ie,0plots,txt 
finish 




A.4 Corrosion Model Convergence Studies 
A.4.1 Dogbone Specimen Model 
Owing to the simplicity of the dogbone specimen model geometry and the 
deformation induced by the uniaxial load, it was found that the predicted nodal 
displacement, element stress and element strain results were all converged even 
when a relatively large Le was used. Therefore, a mesh sensitivity study was 
performed, as shown in Figure A.2(a), in which the predicted mass loss results were 
converged to within approximately 3% when using Le = 0.012 mm. Using this Le 
value, a suitable time step of 1 hour was identified in a similar iterative process, as 
shown in Figure A.2(b). 
 
Figure A.2 (a) Plot of predicted dogbone specimen mass loss over time for varying 
average element size (Le) values, (b) Plot of predicted dogbone specimen mass loss 
over time for varying time step (∆t) values 
A.4.2 Stent Model 
For the RUC stent model, predicted nodal displacement, element stress and strain 
and radial stiffness results were all found to have converged within 2% when using 
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Le =  0.015. Therefore, based on the results of the convergence study shown in 
Figure A.3, Le and ∆t values of 0.012 mm and 1 hour were selected, respectively. 
 
Figure A.3 (a) Plot of predicted stent mass loss over time for varying average 
element size (Le) values, (b) Plot of predicted stent mass loss over time for varying 
time step (∆t) values 
